id	sid	tid	token	lemma	pos
work_il2ytikkcvhktlpwxw46dgflri	1	1	Anti	Anti	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	2	-	-	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	3	Hla	hla	JJ
work_il2ytikkcvhktlpwxw46dgflri	1	4	Antibodies	Antibodies	NNPS
work_il2ytikkcvhktlpwxw46dgflri	1	5	Predict	Predict	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	6	Graft	Graft	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	7	Failure	Failure	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	8	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	1	9	Time	Time	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	10	To	to	IN
work_il2ytikkcvhktlpwxw46dgflri	1	11	Engraftment	Engraftment	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	12	And	and	CC
work_il2ytikkcvhktlpwxw46dgflri	1	13	Umbilical	Umbilical	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	14	Cord	Cord	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	15	Unit	Unit	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	16	Dominance	dominance	IN
work_il2ytikkcvhktlpwxw46dgflri	1	17	In	in	IN
work_il2ytikkcvhktlpwxw46dgflri	1	18	Double	double	JJ
work_il2ytikkcvhktlpwxw46dgflri	1	19	Umbilical	Umbilical	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	20	Cord	Cord	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	21	Blood	Blood	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	22	Transplantation	Transplantation	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	23	Poster	Poster	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	24	Session	Session	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	25	I	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	1	26	S225	S225	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	27	Conclusion	conclusion	NN
work_il2ytikkcvhktlpwxw46dgflri	1	28	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	1	29	Our	-PRON-	PRP$
work_il2ytikkcvhktlpwxw46dgflri	1	30	results	result	NNS
work_il2ytikkcvhktlpwxw46dgflri	1	31	indicate	indicate	VBP
work_il2ytikkcvhktlpwxw46dgflri	1	32	an	an	DT
work_il2ytikkcvhktlpwxw46dgflri	1	33	increased	increase	VBN
work_il2ytikkcvhktlpwxw46dgflri	1	34	risk	risk	NN
work_il2ytikkcvhktlpwxw46dgflri	1	35	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	1	36	acute	acute	JJ
work_il2ytikkcvhktlpwxw46dgflri	1	37	GvHD	GvHD	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	38	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	1	39	association	association	NN
work_il2ytikkcvhktlpwxw46dgflri	1	40	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	1	41	DPB1	DPB1	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	42	mismatch	mismatch	NN
work_il2ytikkcvhktlpwxw46dgflri	1	43	regardless	regardless	RB
work_il2ytikkcvhktlpwxw46dgflri	1	44	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	1	45	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	1	46	TCE	TCE	NNP
work_il2ytikkcvhktlpwxw46dgflri	1	47	classifica-	classifica-	NN
work_il2ytikkcvhktlpwxw46dgflri	1	48	tion	tion	NN
work_il2ytikkcvhktlpwxw46dgflri	1	49	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	2	1	TCE	TCE	NNP
work_il2ytikkcvhktlpwxw46dgflri	2	2	classification	classification	NN
work_il2ytikkcvhktlpwxw46dgflri	2	3	did	do	VBD
work_il2ytikkcvhktlpwxw46dgflri	2	4	not	not	RB
work_il2ytikkcvhktlpwxw46dgflri	2	5	correlate	correlate	VB
work_il2ytikkcvhktlpwxw46dgflri	2	6	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	2	7	any	any	DT
work_il2ytikkcvhktlpwxw46dgflri	2	8	transplant	transplant	NN
work_il2ytikkcvhktlpwxw46dgflri	2	9	out-	out-	RB
work_il2ytikkcvhktlpwxw46dgflri	2	10	come	come	VBP
work_il2ytikkcvhktlpwxw46dgflri	2	11	considered	consider	VBN
work_il2ytikkcvhktlpwxw46dgflri	2	12	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	2	13	our	-PRON-	PRP$
work_il2ytikkcvhktlpwxw46dgflri	2	14	cohort	cohort	NN
work_il2ytikkcvhktlpwxw46dgflri	2	15	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	3	1	This	this	DT
work_il2ytikkcvhktlpwxw46dgflri	3	2	analysis	analysis	NN
work_il2ytikkcvhktlpwxw46dgflri	3	3	does	do	VBZ
work_il2ytikkcvhktlpwxw46dgflri	3	4	not	not	RB
work_il2ytikkcvhktlpwxw46dgflri	3	5	support	support	VB
work_il2ytikkcvhktlpwxw46dgflri	3	6	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	3	7	clinical	clinical	JJ
work_il2ytikkcvhktlpwxw46dgflri	3	8	relevance	relevance	NN
work_il2ytikkcvhktlpwxw46dgflri	3	9	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	3	10	ranking	rank	VBG
work_il2ytikkcvhktlpwxw46dgflri	3	11	DPB1	DPB1	NNP
work_il2ytikkcvhktlpwxw46dgflri	3	12	mismatches	mismatch	NNS
work_il2ytikkcvhktlpwxw46dgflri	3	13	based	base	VBN
work_il2ytikkcvhktlpwxw46dgflri	3	14	on	on	IN
work_il2ytikkcvhktlpwxw46dgflri	3	15	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	3	16	TCE	TCE	NNP
work_il2ytikkcvhktlpwxw46dgflri	3	17	algorithm	algorithm	NN
work_il2ytikkcvhktlpwxw46dgflri	3	18	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	4	1	195	195	CD
work_il2ytikkcvhktlpwxw46dgflri	4	2	A	a	DT
work_il2ytikkcvhktlpwxw46dgflri	4	3	SCORING	scoring	NN
work_il2ytikkcvhktlpwxw46dgflri	4	4	SYSTEM	system	NN
work_il2ytikkcvhktlpwxw46dgflri	4	5	PREDICTING	predict	VBG
work_il2ytikkcvhktlpwxw46dgflri	4	6	OUTCOME	outcome	NN
work_il2ytikkcvhktlpwxw46dgflri	4	7	AFTER	after	IN
work_il2ytikkcvhktlpwxw46dgflri	4	8	UNRELATED	UNRELATED	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	9	DONOR	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	4	10	STEM	stem	JJ
work_il2ytikkcvhktlpwxw46dgflri	4	11	CELL	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	4	12	TRANSPLANTATION	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	4	13	IN	in	IN
work_il2ytikkcvhktlpwxw46dgflri	4	14	PRIMARY	PRIMARY	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	15	REFRACTORY	REFRACTORY	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	16	ACUTE	ACUTE	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	17	MYE-	MYE-	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	18	LOID	LOID	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	19	LEUKEMIA	LEUKEMIA	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	20	Craddock	Craddock	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	21	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	22	C.F.1	C.F.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	23	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	24	Labopin	Labopin	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	25	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	26	M.2	M.2	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	27	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	28	Schmid	Schmid	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	29	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	30	C.3	C.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	31	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	32	Mohty	Mohty	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	33	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	34	M.4	M.4	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	35	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	36	Rocha	Rocha	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	37	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	38	V.5	V.5	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	39	1Queen	1Queen	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	40	Elizabeth	Elizabeth	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	41	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	42	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	43	Birmingham	Birmingham	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	44	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	45	United	United	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	46	Kingdom	Kingdom	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	47	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	4	48	2Faculte	2Faculte	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	49	de	de	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	50	Medecine	Medecine	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	51	St	St	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	52	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	4	53	Antoine	Antoine	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	54	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	55	Paris	Paris	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	56	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	57	France	France	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	58	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	4	59	3Klinikum	3Klinikum	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	60	Augsburg	Augsburg	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	61	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	62	Germany	Germany	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	63	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	4	64	4Nantes	4Nantes	NNPS
work_il2ytikkcvhktlpwxw46dgflri	4	65	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	66	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	67	Nantes	Nantes	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	68	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	69	France	France	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	70	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	4	71	5Hopital	5Hopital	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	72	St	St	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	73	Louis	Louis	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	74	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	75	Paris	Paris	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	76	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	4	77	France	France	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	78	Treatment	Treatment	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	79	options	option	NNS
work_il2ytikkcvhktlpwxw46dgflri	4	80	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	4	81	adults	adult	NNS
work_il2ytikkcvhktlpwxw46dgflri	4	82	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	4	83	primary	primary	JJ
work_il2ytikkcvhktlpwxw46dgflri	4	84	refractory	refractory	NN
work_il2ytikkcvhktlpwxw46dgflri	4	85	AML	AML	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	86	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	4	87	PREF	PREF	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	88	AML	AML	NNP
work_il2ytikkcvhktlpwxw46dgflri	4	89	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	4	90	are	be	VBP
work_il2ytikkcvhktlpwxw46dgflri	4	91	extremely	extremely	RB
work_il2ytikkcvhktlpwxw46dgflri	4	92	limited	limited	JJ
work_il2ytikkcvhktlpwxw46dgflri	4	93	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	5	1	Whilst	whilst	IN
work_il2ytikkcvhktlpwxw46dgflri	5	2	sibling	sible	VBG
work_il2ytikkcvhktlpwxw46dgflri	5	3	allogeneic	allogeneic	NN
work_il2ytikkcvhktlpwxw46dgflri	5	4	stem	stem	NN
work_il2ytikkcvhktlpwxw46dgflri	5	5	cell	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	5	6	transplantation	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	5	7	can	can	MD
work_il2ytikkcvhktlpwxw46dgflri	5	8	result	result	VB
work_il2ytikkcvhktlpwxw46dgflri	5	9	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	5	10	long	long	JJ
work_il2ytikkcvhktlpwxw46dgflri	5	11	term	term	NN
work_il2ytikkcvhktlpwxw46dgflri	5	12	survival	survival	NN
work_il2ytikkcvhktlpwxw46dgflri	5	13	most	most	JJS
work_il2ytikkcvhktlpwxw46dgflri	5	14	pa-	pa-	NN
work_il2ytikkcvhktlpwxw46dgflri	5	15	tients	tient	NNS
work_il2ytikkcvhktlpwxw46dgflri	5	16	lack	lack	VBP
work_il2ytikkcvhktlpwxw46dgflri	5	17	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	5	18	matched	match	VBN
work_il2ytikkcvhktlpwxw46dgflri	5	19	family	family	NN
work_il2ytikkcvhktlpwxw46dgflri	5	20	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	5	21	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	5	22	are	be	VBP
work_il2ytikkcvhktlpwxw46dgflri	5	23	destined	destine	VBN
work_il2ytikkcvhktlpwxw46dgflri	5	24	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	5	25	die	die	VB
work_il2ytikkcvhktlpwxw46dgflri	5	26	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	5	27	refrac-	refrac-	NNP
work_il2ytikkcvhktlpwxw46dgflri	5	28	tory	tory	NN
work_il2ytikkcvhktlpwxw46dgflri	5	29	disease	disease	NN
work_il2ytikkcvhktlpwxw46dgflri	5	30	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	6	1	Greater	great	JJR
work_il2ytikkcvhktlpwxw46dgflri	6	2	availability	availability	NN
work_il2ytikkcvhktlpwxw46dgflri	6	3	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	6	4	unrelated	unrelated	JJ
work_il2ytikkcvhktlpwxw46dgflri	6	5	donors	donor	NNS
work_il2ytikkcvhktlpwxw46dgflri	6	6	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	6	7	improvements	improvement	NNS
work_il2ytikkcvhktlpwxw46dgflri	6	8	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	6	9	supportive	supportive	JJ
work_il2ytikkcvhktlpwxw46dgflri	6	10	care	care	NN
work_il2ytikkcvhktlpwxw46dgflri	6	11	have	have	VBP
work_il2ytikkcvhktlpwxw46dgflri	6	12	increased	increase	VBN
work_il2ytikkcvhktlpwxw46dgflri	6	13	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	6	14	proportion	proportion	NN
work_il2ytikkcvhktlpwxw46dgflri	6	15	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	6	16	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	6	17	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	6	18	PREF	PREF	NNP
work_il2ytikkcvhktlpwxw46dgflri	6	19	AML	AML	NNP
work_il2ytikkcvhktlpwxw46dgflri	6	20	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	6	21	whom	whom	WP
work_il2ytikkcvhktlpwxw46dgflri	6	22	allografting	allografte	VBG
work_il2ytikkcvhktlpwxw46dgflri	6	23	is	be	VBZ
work_il2ytikkcvhktlpwxw46dgflri	6	24	technically	technically	RB
work_il2ytikkcvhktlpwxw46dgflri	6	25	fea-	fea-	DT
work_il2ytikkcvhktlpwxw46dgflri	6	26	sible	sible	NN
work_il2ytikkcvhktlpwxw46dgflri	6	27	but	but	CC
work_il2ytikkcvhktlpwxw46dgflri	6	28	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	6	29	outcome	outcome	NN
work_il2ytikkcvhktlpwxw46dgflri	6	30	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	6	31	unrelated	unrelated	JJ
work_il2ytikkcvhktlpwxw46dgflri	6	32	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	6	33	transplantation	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	6	34	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	6	35	this	this	DT
work_il2ytikkcvhktlpwxw46dgflri	6	36	population	population	NN
work_il2ytikkcvhktlpwxw46dgflri	6	37	has	have	VBZ
work_il2ytikkcvhktlpwxw46dgflri	6	38	not	not	RB
work_il2ytikkcvhktlpwxw46dgflri	6	39	been	be	VBN
work_il2ytikkcvhktlpwxw46dgflri	6	40	extensively	extensively	RB
work_il2ytikkcvhktlpwxw46dgflri	6	41	studied	study	VBN
work_il2ytikkcvhktlpwxw46dgflri	6	42	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	7	1	We	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	7	2	therefore	therefore	RB
work_il2ytikkcvhktlpwxw46dgflri	7	3	analysed	analyse	VBD
work_il2ytikkcvhktlpwxw46dgflri	7	4	overall	overall	JJ
work_il2ytikkcvhktlpwxw46dgflri	7	5	survival	survival	NN
work_il2ytikkcvhktlpwxw46dgflri	7	6	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	7	7	168	168	CD
work_il2ytikkcvhktlpwxw46dgflri	7	8	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	7	9	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	7	10	PREF	PREF	NNP
work_il2ytikkcvhktlpwxw46dgflri	7	11	AML	AML	NNP
work_il2ytikkcvhktlpwxw46dgflri	7	12	who	who	WP
work_il2ytikkcvhktlpwxw46dgflri	7	13	underwent	undergo	VBD
work_il2ytikkcvhktlpwxw46dgflri	7	14	unrelated	unrelated	JJ
work_il2ytikkcvhktlpwxw46dgflri	7	15	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	7	16	transplantation	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	7	17	between	between	IN
work_il2ytikkcvhktlpwxw46dgflri	7	18	1994	1994	CD
work_il2ytikkcvhktlpwxw46dgflri	7	19	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	7	20	2006	2006	CD
work_il2ytikkcvhktlpwxw46dgflri	7	21	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	7	22	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	7	23	me-	me-	JJ
work_il2ytikkcvhktlpwxw46dgflri	7	24	dian	dian	JJ
work_il2ytikkcvhktlpwxw46dgflri	7	25	follow	follow	NN
work_il2ytikkcvhktlpwxw46dgflri	7	26	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	7	27	up	up	NN
work_il2ytikkcvhktlpwxw46dgflri	7	28	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	7	29	59	59	CD
work_il2ytikkcvhktlpwxw46dgflri	7	30	months	month	NNS
work_il2ytikkcvhktlpwxw46dgflri	7	31	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	7	32	15	15	CD
work_il2ytikkcvhktlpwxw46dgflri	7	33	-	-	SYM
work_il2ytikkcvhktlpwxw46dgflri	7	34	172	172	CD
work_il2ytikkcvhktlpwxw46dgflri	7	35	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	7	36	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	8	1	80	80	CD
work_il2ytikkcvhktlpwxw46dgflri	8	2	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	8	3	received	receive	VBD
work_il2ytikkcvhktlpwxw46dgflri	8	4	three	three	CD
work_il2ytikkcvhktlpwxw46dgflri	8	5	or	or	CC
work_il2ytikkcvhktlpwxw46dgflri	8	6	more	more	JJR
work_il2ytikkcvhktlpwxw46dgflri	8	7	courses	course	NNS
work_il2ytikkcvhktlpwxw46dgflri	8	8	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	8	9	induction	induction	NN
work_il2ytikkcvhktlpwxw46dgflri	8	10	chemotherapy	chemotherapy	NN
work_il2ytikkcvhktlpwxw46dgflri	8	11	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	9	1	The	the	DT
work_il2ytikkcvhktlpwxw46dgflri	9	2	median	median	JJ
work_il2ytikkcvhktlpwxw46dgflri	9	3	percentage	percentage	NN
work_il2ytikkcvhktlpwxw46dgflri	9	4	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	9	5	bone	bone	NN
work_il2ytikkcvhktlpwxw46dgflri	9	6	marrow	marrow	NN
work_il2ytikkcvhktlpwxw46dgflri	9	7	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	9	8	BM	BM	NNP
work_il2ytikkcvhktlpwxw46dgflri	9	9	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	9	10	blasts	blast	NNS
work_il2ytikkcvhktlpwxw46dgflri	9	11	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	9	12	transplant	transplant	NN
work_il2ytikkcvhktlpwxw46dgflri	9	13	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	9	14	39	39	CD
work_il2ytikkcvhktlpwxw46dgflri	9	15	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	9	16	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	10	1	The	the	DT
work_il2ytikkcvhktlpwxw46dgflri	10	2	5-year	5-year	CD
work_il2ytikkcvhktlpwxw46dgflri	10	3	overall	overall	JJ
work_il2ytikkcvhktlpwxw46dgflri	10	4	survival	survival	NN
work_il2ytikkcvhktlpwxw46dgflri	10	5	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	10	6	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	10	7	whole	whole	JJ
work_il2ytikkcvhktlpwxw46dgflri	10	8	group	group	NN
work_il2ytikkcvhktlpwxw46dgflri	10	9	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	10	10	22	22	CD
work_il2ytikkcvhktlpwxw46dgflri	10	11	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	10	12	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	11	1	In	in	IN
work_il2ytikkcvhktlpwxw46dgflri	11	2	multivariate	multivariate	JJ
work_il2ytikkcvhktlpwxw46dgflri	11	3	anal-	anal-	JJ
work_il2ytikkcvhktlpwxw46dgflri	11	4	ysis	ysis	NN
work_il2ytikkcvhktlpwxw46dgflri	11	5	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	11	6	fewer	few	JJR
work_il2ytikkcvhktlpwxw46dgflri	11	7	than	than	IN
work_il2ytikkcvhktlpwxw46dgflri	11	8	three	three	CD
work_il2ytikkcvhktlpwxw46dgflri	11	9	courses	course	NNS
work_il2ytikkcvhktlpwxw46dgflri	11	10	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	11	11	induction	induction	NN
work_il2ytikkcvhktlpwxw46dgflri	11	12	chemotherapy	chemotherapy	NN
work_il2ytikkcvhktlpwxw46dgflri	11	13	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	11	14	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	11	15	lower	low	JJR
work_il2ytikkcvhktlpwxw46dgflri	11	16	percentage	percentage	NN
work_il2ytikkcvhktlpwxw46dgflri	11	17	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	11	18	BM	BM	NNP
work_il2ytikkcvhktlpwxw46dgflri	11	19	blasts	blast	NNS
work_il2ytikkcvhktlpwxw46dgflri	11	20	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	11	21	transplant	transplant	NN
work_il2ytikkcvhktlpwxw46dgflri	11	22	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	11	23	patient	patient	JJ
work_il2ytikkcvhktlpwxw46dgflri	11	24	CMV	CMV	NNP
work_il2ytikkcvhktlpwxw46dgflri	11	25	seropositiv-	seropositiv-	NN
work_il2ytikkcvhktlpwxw46dgflri	11	26	ity	ity	NN
work_il2ytikkcvhktlpwxw46dgflri	11	27	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	11	28	associated	associate	VBN
work_il2ytikkcvhktlpwxw46dgflri	11	29	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	11	30	improved	improved	JJ
work_il2ytikkcvhktlpwxw46dgflri	11	31	survival	survival	NN
work_il2ytikkcvhktlpwxw46dgflri	11	32	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	12	1	We	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	12	2	used	use	VBD
work_il2ytikkcvhktlpwxw46dgflri	12	3	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	12	4	prognostic	prognostic	JJ
work_il2ytikkcvhktlpwxw46dgflri	12	5	factors	factor	NNS
work_il2ytikkcvhktlpwxw46dgflri	12	6	identified	identify	VBN
work_il2ytikkcvhktlpwxw46dgflri	12	7	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	12	8	multivariate	multivariate	JJ
work_il2ytikkcvhktlpwxw46dgflri	12	9	analysis	analysis	NN
work_il2ytikkcvhktlpwxw46dgflri	12	10	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	12	11	develop	develop	VB
work_il2ytikkcvhktlpwxw46dgflri	12	12	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	12	13	scoring	score	VBG
work_il2ytikkcvhktlpwxw46dgflri	12	14	sys-	sys-	NN
work_il2ytikkcvhktlpwxw46dgflri	12	15	tem	tem	NN
work_il2ytikkcvhktlpwxw46dgflri	12	16	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	13	1	This	this	DT
work_il2ytikkcvhktlpwxw46dgflri	13	2	allowed	allow	VBD
work_il2ytikkcvhktlpwxw46dgflri	13	3	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	13	4	delineation	delineation	NN
work_il2ytikkcvhktlpwxw46dgflri	13	5	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	13	6	four	four	CD
work_il2ytikkcvhktlpwxw46dgflri	13	7	prognostic	prognostic	JJ
work_il2ytikkcvhktlpwxw46dgflri	13	8	groups	group	NNS
work_il2ytikkcvhktlpwxw46dgflri	13	9	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	13	10	survival	survival	NN
work_il2ytikkcvhktlpwxw46dgflri	13	11	rates	rate	NNS
work_il2ytikkcvhktlpwxw46dgflri	13	12	ranging	range	VBG
work_il2ytikkcvhktlpwxw46dgflri	13	13	between	between	IN
work_il2ytikkcvhktlpwxw46dgflri	13	14	44	44	CD
work_il2ytikkcvhktlpwxw46dgflri	13	15	6	6	CD
work_il2ytikkcvhktlpwxw46dgflri	13	16	11	11	CD
work_il2ytikkcvhktlpwxw46dgflri	13	17	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	13	18	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	13	19	0	0	CD
work_il2ytikkcvhktlpwxw46dgflri	13	20	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	13	21	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	14	1	This	this	DT
work_il2ytikkcvhktlpwxw46dgflri	14	2	study	study	NN
work_il2ytikkcvhktlpwxw46dgflri	14	3	dem-	dem-	RB
work_il2ytikkcvhktlpwxw46dgflri	14	4	onstrates	onstrate	VBZ
work_il2ytikkcvhktlpwxw46dgflri	14	5	an	an	DT
work_il2ytikkcvhktlpwxw46dgflri	14	6	important	important	JJ
work_il2ytikkcvhktlpwxw46dgflri	14	7	role	role	NN
work_il2ytikkcvhktlpwxw46dgflri	14	8	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	14	9	unrelated	unrelated	JJ
work_il2ytikkcvhktlpwxw46dgflri	14	10	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	14	11	transplantation	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	14	12	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	14	13	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	14	14	management	management	NN
work_il2ytikkcvhktlpwxw46dgflri	14	15	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	14	16	selected	select	VBN
work_il2ytikkcvhktlpwxw46dgflri	14	17	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	14	18	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	14	19	PREF	PREF	NNP
work_il2ytikkcvhktlpwxw46dgflri	14	20	AML	AML	NNP
work_il2ytikkcvhktlpwxw46dgflri	14	21	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	14	22	confirms	confirm	VBZ
work_il2ytikkcvhktlpwxw46dgflri	14	23	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	14	24	importance	importance	NN
work_il2ytikkcvhktlpwxw46dgflri	14	25	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	14	26	initiating	initiate	VBG
work_il2ytikkcvhktlpwxw46dgflri	14	27	an	an	DT
work_il2ytikkcvhktlpwxw46dgflri	14	28	urgent	urgent	JJ
work_il2ytikkcvhktlpwxw46dgflri	14	29	unrelated	unrelated	JJ
work_il2ytikkcvhktlpwxw46dgflri	14	30	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	14	31	search	search	NN
work_il2ytikkcvhktlpwxw46dgflri	14	32	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	14	33	pa-	pa-	NN
work_il2ytikkcvhktlpwxw46dgflri	14	34	tients	tient	NNS
work_il2ytikkcvhktlpwxw46dgflri	14	35	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	14	36	no	no	DT
work_il2ytikkcvhktlpwxw46dgflri	14	37	matched	match	VBN
work_il2ytikkcvhktlpwxw46dgflri	14	38	sibling	sibling	NN
work_il2ytikkcvhktlpwxw46dgflri	14	39	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	14	40	who	who	WP
work_il2ytikkcvhktlpwxw46dgflri	14	41	fail	fail	VBP
work_il2ytikkcvhktlpwxw46dgflri	14	42	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	14	43	respond	respond	VB
work_il2ytikkcvhktlpwxw46dgflri	14	44	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	14	45	induc-	induc-	NNP
work_il2ytikkcvhktlpwxw46dgflri	14	46	tion	tion	NNP
work_il2ytikkcvhktlpwxw46dgflri	14	47	chemotherapy	chemotherapy	NN
work_il2ytikkcvhktlpwxw46dgflri	14	48	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	15	1	Pre	pre	JJ
work_il2ytikkcvhktlpwxw46dgflri	15	2	-	-	JJ
work_il2ytikkcvhktlpwxw46dgflri	15	3	transplant	transplant	JJ
work_il2ytikkcvhktlpwxw46dgflri	15	4	factors	factor	NNS
work_il2ytikkcvhktlpwxw46dgflri	15	5	allow	allow	VBP
work_il2ytikkcvhktlpwxw46dgflri	15	6	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	15	7	identification	identification	NN
work_il2ytikkcvhktlpwxw46dgflri	15	8	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	15	9	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	15	10	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	15	11	PREF	PREF	NNP
work_il2ytikkcvhktlpwxw46dgflri	15	12	AML	AML	NNP
work_il2ytikkcvhktlpwxw46dgflri	15	13	who	who	WP
work_il2ytikkcvhktlpwxw46dgflri	15	14	are	be	VBP
work_il2ytikkcvhktlpwxw46dgflri	15	15	likely	likely	JJ
work_il2ytikkcvhktlpwxw46dgflri	15	16	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	15	17	benefit	benefit	VB
work_il2ytikkcvhktlpwxw46dgflri	15	18	from	from	IN
work_il2ytikkcvhktlpwxw46dgflri	15	19	unre-	unre-	NNP
work_il2ytikkcvhktlpwxw46dgflri	15	20	lated	late	VBN
work_il2ytikkcvhktlpwxw46dgflri	15	21	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	15	22	transplantation	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	15	23	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	16	1	196	196	CD
work_il2ytikkcvhktlpwxw46dgflri	16	2	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	3	DISPARITY	DISPARITY	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	4	AND	and	CC
work_il2ytikkcvhktlpwxw46dgflri	16	5	RAPID	rapid	NN
work_il2ytikkcvhktlpwxw46dgflri	16	6	IMMUNE	IMMUNE	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	7	RECONSTITUTION	RECONSTITUTION	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	8	DO	do	VBP
work_il2ytikkcvhktlpwxw46dgflri	16	9	NOT	not	RB
work_il2ytikkcvhktlpwxw46dgflri	16	10	OVER-	over-	VB
work_il2ytikkcvhktlpwxw46dgflri	16	11	COME	come	VB
work_il2ytikkcvhktlpwxw46dgflri	16	12	PROPENSITY	PROPENSITY	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	13	TO	to	IN
work_il2ytikkcvhktlpwxw46dgflri	16	14	RELAPSE	RELAPSE	NNS
work_il2ytikkcvhktlpwxw46dgflri	16	15	IN	in	IN
work_il2ytikkcvhktlpwxw46dgflri	16	16	PATIENTS	PATIENTS	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	17	UNDERGOING	undergo	VBG
work_il2ytikkcvhktlpwxw46dgflri	16	18	HAPLOI-	HAPLOI-	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	19	DENTICAL	DENTICAL	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	20	HEMATOPOIETIC	HEMATOPOIETIC	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	21	STEM	stem	NN
work_il2ytikkcvhktlpwxw46dgflri	16	22	CELL	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	16	23	TRANSPLANT	transplant	NN
work_il2ytikkcvhktlpwxw46dgflri	16	24	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	16	25	HSCT	HSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	26	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	16	27	WITH	with	IN
work_il2ytikkcvhktlpwxw46dgflri	16	28	PERSISTENT	PERSISTENT	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	29	DISEASE	DISEASE	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	30	AT	at	IN
work_il2ytikkcvhktlpwxw46dgflri	16	31	THE	the	DT
work_il2ytikkcvhktlpwxw46dgflri	16	32	TIME	time	NN
work_il2ytikkcvhktlpwxw46dgflri	16	33	OF	of	IN
work_il2ytikkcvhktlpwxw46dgflri	16	34	TRANSPLANT	TRANSPLANT	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	35	Grosso	Grosso	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	36	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	37	D.1	D.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	38	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	39	Alpdogan	Alpdogan	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	40	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	41	O.1	O.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	42	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	43	Carabasi	Carabasi	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	44	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	45	M.1	M.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	46	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	47	Colombe	Colombe	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	48	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	49	B.2	B.2	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	50	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	51	Cornett	Cornett	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	52	Farley	Farley	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	53	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	54	P.3	P.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	55	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	56	Filicko	Filicko	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	57	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	16	58	O’Hara	O’Hara	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	59	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	60	J.1	J.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	61	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	62	Flomenberg	Flomenberg	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	63	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	64	P.4	P.4	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	65	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	66	Gitelson	Gitelson	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	67	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	68	E.1	E.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	69	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	70	Kasner	Kasner	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	71	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	72	M.1	M.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	73	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	74	Martinez	Martinez	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	75	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	16	76	Outschoorn	Outschoorn	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	77	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	78	U.1	U.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	79	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	80	O’Hara	O’Hara	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	81	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	82	W.5	W.5	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	83	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	84	Wagner	Wagner	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	85	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	86	J.L.1	J.L.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	87	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	88	Weiss	Weiss	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	89	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	90	M.1	M.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	91	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	92	Werner	Werner	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	93	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	16	94	Wasik	Wasik	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	95	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	96	M.6	M.6	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	97	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	98	Flomenberg	Flomenberg	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	99	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	100	N.1	N.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	101	1Thomas	1Thomas	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	102	Jefferson	Jefferson	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	103	University	University	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	104	Kimmel	Kimmel	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	105	Cancer	Cancer	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	106	Center	Center	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	107	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	108	Philadelphia	Philadelphia	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	109	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	110	PA	pa	NN
work_il2ytikkcvhktlpwxw46dgflri	16	111	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	16	112	2Thomas	2thomas	CD
work_il2ytikkcvhktlpwxw46dgflri	16	113	Jefferson	Jefferson	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	114	University	University	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	115	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	116	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	117	Philadelphia	Philadelphia	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	118	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	119	PA	PA	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	120	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	16	121	3Thomas	3Thomas	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	122	Jefferson	Jefferson	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	123	University	University	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	124	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	125	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	126	Philadelphia	Philadelphia	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	127	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	128	PA	pa	NN
work_il2ytikkcvhktlpwxw46dgflri	16	129	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	16	130	4Thomas	4Thomas	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	131	Jefferson	Jefferson	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	132	University	University	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	133	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	134	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	135	Philadelphia	Philadelphia	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	136	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	137	PA	pa	NN
work_il2ytikkcvhktlpwxw46dgflri	16	138	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	16	139	5Thomas	5Thomas	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	140	Jefferson	Jefferson	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	141	University	University	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	142	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	143	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	144	Philadelphia	Philadelphia	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	145	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	146	PA	PA	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	147	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	16	148	6Thomas	6Thomas	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	149	Jefferson	Jefferson	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	150	University	University	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	151	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	152	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	153	Philadelphia	Philadelphia	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	154	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	155	PA	PA	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	156	While	while	IN
work_il2ytikkcvhktlpwxw46dgflri	16	157	increasing	increase	VBG
work_il2ytikkcvhktlpwxw46dgflri	16	158	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	159	disparity	disparity	NN
work_il2ytikkcvhktlpwxw46dgflri	16	160	is	be	VBZ
work_il2ytikkcvhktlpwxw46dgflri	16	161	known	know	VBN
work_il2ytikkcvhktlpwxw46dgflri	16	162	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	16	163	be	be	VB
work_il2ytikkcvhktlpwxw46dgflri	16	164	associated	associate	VBN
work_il2ytikkcvhktlpwxw46dgflri	16	165	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	16	166	increased	increase	VBN
work_il2ytikkcvhktlpwxw46dgflri	16	167	risk	risk	NN
work_il2ytikkcvhktlpwxw46dgflri	16	168	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	16	169	significant	significant	JJ
work_il2ytikkcvhktlpwxw46dgflri	16	170	graft	graft	NN
work_il2ytikkcvhktlpwxw46dgflri	16	171	versus	versus	IN
work_il2ytikkcvhktlpwxw46dgflri	16	172	host	host	NN
work_il2ytikkcvhktlpwxw46dgflri	16	173	disease	disease	NN
work_il2ytikkcvhktlpwxw46dgflri	16	174	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	16	175	GVHD	GVHD	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	176	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	16	177	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	178	there	there	EX
work_il2ytikkcvhktlpwxw46dgflri	16	179	is	be	VBZ
work_il2ytikkcvhktlpwxw46dgflri	16	180	less	less	JJR
work_il2ytikkcvhktlpwxw46dgflri	16	181	data	datum	NNS
work_il2ytikkcvhktlpwxw46dgflri	16	182	as	as	IN
work_il2ytikkcvhktlpwxw46dgflri	16	183	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	16	184	whether	whether	IN
work_il2ytikkcvhktlpwxw46dgflri	16	185	increasing	increase	VBG
work_il2ytikkcvhktlpwxw46dgflri	16	186	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	187	disparity	disparity	NN
work_il2ytikkcvhktlpwxw46dgflri	16	188	is	be	VBZ
work_il2ytikkcvhktlpwxw46dgflri	16	189	corre-	corre-	RB
work_il2ytikkcvhktlpwxw46dgflri	16	190	lated	late	VBN
work_il2ytikkcvhktlpwxw46dgflri	16	191	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	16	192	stronger	strong	JJR
work_il2ytikkcvhktlpwxw46dgflri	16	193	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	16	194	clinically	clinically	RB
work_il2ytikkcvhktlpwxw46dgflri	16	195	significant	significant	JJ
work_il2ytikkcvhktlpwxw46dgflri	16	196	graft	graft	NN
work_il2ytikkcvhktlpwxw46dgflri	16	197	versus	versus	IN
work_il2ytikkcvhktlpwxw46dgflri	16	198	leukemia	leukemia	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	199	ef-	ef-	NNP
work_il2ytikkcvhktlpwxw46dgflri	16	200	fects	fect	NNS
work_il2ytikkcvhktlpwxw46dgflri	16	201	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	17	1	We	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	17	2	examined	examine	VBD
work_il2ytikkcvhktlpwxw46dgflri	17	3	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	17	4	group	group	NN
work_il2ytikkcvhktlpwxw46dgflri	17	5	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	17	6	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	17	7	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	17	8	acute	acute	JJ
work_il2ytikkcvhktlpwxw46dgflri	17	9	leukemia	leukemia	NNP
work_il2ytikkcvhktlpwxw46dgflri	17	10	undergoing	undergo	VBG
work_il2ytikkcvhktlpwxw46dgflri	17	11	haploidentical	haploidentical	JJ
work_il2ytikkcvhktlpwxw46dgflri	17	12	HSCT	HSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	17	13	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	17	14	assess	assess	VB
work_il2ytikkcvhktlpwxw46dgflri	17	15	whether	whether	IN
work_il2ytikkcvhktlpwxw46dgflri	17	16	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	17	17	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	17	18	there	there	EX
work_il2ytikkcvhktlpwxw46dgflri	17	19	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	17	20	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	17	21	marked	marked	JJ
work_il2ytikkcvhktlpwxw46dgflri	17	22	difference	difference	NN
work_il2ytikkcvhktlpwxw46dgflri	17	23	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	17	24	relapse	relapse	NN
work_il2ytikkcvhktlpwxw46dgflri	17	25	rates	rate	NNS
work_il2ytikkcvhktlpwxw46dgflri	17	26	based	base	VBN
work_il2ytikkcvhktlpwxw46dgflri	17	27	on	on	IN
work_il2ytikkcvhktlpwxw46dgflri	17	28	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	17	29	degree	degree	NN
work_il2ytikkcvhktlpwxw46dgflri	17	30	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	17	31	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	17	32	mismatch	mismatch	NN
work_il2ytikkcvhktlpwxw46dgflri	17	33	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	17	34	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	17	35	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	17	36	if	if	IN
work_il2ytikkcvhktlpwxw46dgflri	17	37	early	early	JJ
work_il2ytikkcvhktlpwxw46dgflri	17	38	recovery	recovery	NN
work_il2ytikkcvhktlpwxw46dgflri	17	39	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	17	40	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	17	41	lymphoid	lymphoid	NNP
work_il2ytikkcvhktlpwxw46dgflri	17	42	subpopula-	subpopula-	NNP
work_il2ytikkcvhktlpwxw46dgflri	17	43	tions	tion	NNS
work_il2ytikkcvhktlpwxw46dgflri	17	44	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	17	45	associated	associate	VBN
work_il2ytikkcvhktlpwxw46dgflri	17	46	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	17	47	less	less	JJR
work_il2ytikkcvhktlpwxw46dgflri	17	48	relapse	relapse	NN
work_il2ytikkcvhktlpwxw46dgflri	17	49	after	after	IN
work_il2ytikkcvhktlpwxw46dgflri	17	50	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	17	51	mismatched	mismatch	VBD
work_il2ytikkcvhktlpwxw46dgflri	17	52	HSCT	HSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	17	53	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	18	1	Thirty	thirty	CD
work_il2ytikkcvhktlpwxw46dgflri	18	2	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	18	3	four	four	CD
work_il2ytikkcvhktlpwxw46dgflri	18	4	adult	adult	NN
work_il2ytikkcvhktlpwxw46dgflri	18	5	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	18	6	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	18	7	AML	AML	NNP
work_il2ytikkcvhktlpwxw46dgflri	18	8	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	18	9	24	24	CD
work_il2ytikkcvhktlpwxw46dgflri	18	10	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	18	11	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	18	12	ALL	all	DT
work_il2ytikkcvhktlpwxw46dgflri	18	13	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	18	14	10	10	CD
work_il2ytikkcvhktlpwxw46dgflri	18	15	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	18	16	underwent	undergo	VBD
work_il2ytikkcvhktlpwxw46dgflri	18	17	haploidentical	haploidentical	JJ
work_il2ytikkcvhktlpwxw46dgflri	18	18	HSCT	HSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	18	19	between	between	IN
work_il2ytikkcvhktlpwxw46dgflri	18	20	2005	2005	CD
work_il2ytikkcvhktlpwxw46dgflri	18	21	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	18	22	2009	2009	CD
work_il2ytikkcvhktlpwxw46dgflri	18	23	using	use	VBG
work_il2ytikkcvhktlpwxw46dgflri	18	24	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	18	25	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	18	26	step	step	NN
work_il2ytikkcvhktlpwxw46dgflri	18	27	process	process	NN
work_il2ytikkcvhktlpwxw46dgflri	18	28	which	which	WDT
work_il2ytikkcvhktlpwxw46dgflri	18	29	separates	separate	VBZ
work_il2ytikkcvhktlpwxw46dgflri	18	30	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	18	31	infusion	infusion	NN
work_il2ytikkcvhktlpwxw46dgflri	18	32	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	18	33	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	18	34	lymphoid	lymphoid	JJ
work_il2ytikkcvhktlpwxw46dgflri	18	35	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	18	36	myeloid	myeloid	JJ
work_il2ytikkcvhktlpwxw46dgflri	18	37	portions	portion	NNS
work_il2ytikkcvhktlpwxw46dgflri	18	38	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	18	39	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	18	40	graft	graft	NN
work_il2ytikkcvhktlpwxw46dgflri	18	41	while	while	IN
work_il2ytikkcvhktlpwxw46dgflri	18	42	attempting	attempt	VBG
work_il2ytikkcvhktlpwxw46dgflri	18	43	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	18	44	render	render	VB
work_il2ytikkcvhktlpwxw46dgflri	18	45	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	18	46	lymphocytes	lymphocyte	NNS
work_il2ytikkcvhktlpwxw46dgflri	18	47	tolerant	tolerant	JJ
work_il2ytikkcvhktlpwxw46dgflri	18	48	utilizing	utilize	VBG
work_il2ytikkcvhktlpwxw46dgflri	18	49	cyclophosphamide	cyclophosphamide	NN
work_il2ytikkcvhktlpwxw46dgflri	18	50	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	19	1	The	the	DT
work_il2ytikkcvhktlpwxw46dgflri	19	2	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	19	3	re-	re-	RB
work_il2ytikkcvhktlpwxw46dgflri	19	4	ceived	ceive	VBD
work_il2ytikkcvhktlpwxw46dgflri	19	5	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	19	6	x10e8	x10e8	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	7	/	/	SYM
work_il2ytikkcvhktlpwxw46dgflri	19	8	kg	kg	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	9	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	19	10	CD3	cd3	NN
work_il2ytikkcvhktlpwxw46dgflri	19	11	cells	cell	NNS
work_il2ytikkcvhktlpwxw46dgflri	19	12	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	19	13	DLI	DLI	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	14	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	19	15	after	after	IN
work_il2ytikkcvhktlpwxw46dgflri	19	16	conditioning	condition	VBG
work_il2ytikkcvhktlpwxw46dgflri	19	17	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	19	18	either	either	DT
work_il2ytikkcvhktlpwxw46dgflri	19	19	TBI	TBI	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	20	12	12	CD
work_il2ytikkcvhktlpwxw46dgflri	19	21	Gy	Gy	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	22	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	19	23	N	n	CD
work_il2ytikkcvhktlpwxw46dgflri	19	24	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	19	25	24	24	CD
work_il2ytikkcvhktlpwxw46dgflri	19	26	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	19	27	or	or	CC
work_il2ytikkcvhktlpwxw46dgflri	19	28	fludarabine	fludarabine	NN
work_il2ytikkcvhktlpwxw46dgflri	19	29	30	30	CD
work_il2ytikkcvhktlpwxw46dgflri	19	30	mg	mg	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	31	/	/	SYM
work_il2ytikkcvhktlpwxw46dgflri	19	32	m2	m2	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	33	�	�	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	34	4	4	CD
work_il2ytikkcvhktlpwxw46dgflri	19	35	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	19	36	thiotepa	thiotepa	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	37	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	19	38	mg	mg	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	39	/	/	SYM
work_il2ytikkcvhktlpwxw46dgflri	19	40	m2	m2	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	41	�	�	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	42	3	3	CD
work_il2ytikkcvhktlpwxw46dgflri	19	43	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	19	44	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	19	45	TBI	TBI	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	46	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	19	47	Gy	Gy	NNP
work_il2ytikkcvhktlpwxw46dgflri	19	48	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	19	49	N	n	CD
work_il2ytikkcvhktlpwxw46dgflri	19	50	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	19	51	10	10	CD
work_il2ytikkcvhktlpwxw46dgflri	19	52	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	19	53	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	20	1	Two	two	CD
work_il2ytikkcvhktlpwxw46dgflri	20	2	days	day	NNS
work_il2ytikkcvhktlpwxw46dgflri	20	3	after	after	IN
work_il2ytikkcvhktlpwxw46dgflri	20	4	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	20	5	DLI	dli	NN
work_il2ytikkcvhktlpwxw46dgflri	20	6	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	20	7	all	all	DT
work_il2ytikkcvhktlpwxw46dgflri	20	8	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	20	9	received	receive	VBD
work_il2ytikkcvhktlpwxw46dgflri	20	10	cyclophosphamide	cyclophosphamide	RB
work_il2ytikkcvhktlpwxw46dgflri	20	11	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	20	12	CY	CY	NNP
work_il2ytikkcvhktlpwxw46dgflri	20	13	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	20	14	60	60	CD
work_il2ytikkcvhktlpwxw46dgflri	20	15	mg	mg	NNP
work_il2ytikkcvhktlpwxw46dgflri	20	16	/	/	SYM
work_il2ytikkcvhktlpwxw46dgflri	20	17	kg	kg	NNP
work_il2ytikkcvhktlpwxw46dgflri	20	18	�	�	NNP
work_il2ytikkcvhktlpwxw46dgflri	20	19	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	20	20	followed	follow	VBN
work_il2ytikkcvhktlpwxw46dgflri	20	21	by	by	IN
work_il2ytikkcvhktlpwxw46dgflri	20	22	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	20	23	CD	CD	NNP
work_il2ytikkcvhktlpwxw46dgflri	20	24	34	34	CD
work_il2ytikkcvhktlpwxw46dgflri	20	25	selected	select	VBN
work_il2ytikkcvhktlpwxw46dgflri	20	26	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	20	27	product	product	NN
work_il2ytikkcvhktlpwxw46dgflri	20	28	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	21	1	The	the	DT
work_il2ytikkcvhktlpwxw46dgflri	21	2	TBI	TBI	NNP
work_il2ytikkcvhktlpwxw46dgflri	21	3	based	base	VBN
work_il2ytikkcvhktlpwxw46dgflri	21	4	regimen	regimen	NN
work_il2ytikkcvhktlpwxw46dgflri	21	5	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	21	6	given	give	VBN
work_il2ytikkcvhktlpwxw46dgflri	21	7	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	21	8	80	80	CD
work_il2ytikkcvhktlpwxw46dgflri	21	9	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	21	10	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	21	11	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	21	12	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	21	13	ALL	all	DT
work_il2ytikkcvhktlpwxw46dgflri	21	14	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	21	15	56	56	CD
work_il2ytikkcvhktlpwxw46dgflri	21	16	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	21	17	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	21	18	AML	AML	NNP
work_il2ytikkcvhktlpwxw46dgflri	21	19	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	22	1	We	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	22	2	exam-	exam-	VBD
work_il2ytikkcvhktlpwxw46dgflri	22	3	ined	ine	VBD
work_il2ytikkcvhktlpwxw46dgflri	22	4	relapse	relapse	NN
work_il2ytikkcvhktlpwxw46dgflri	22	5	rates	rate	NNS
work_il2ytikkcvhktlpwxw46dgflri	22	6	based	base	VBN
work_il2ytikkcvhktlpwxw46dgflri	22	7	on	on	IN
work_il2ytikkcvhktlpwxw46dgflri	22	8	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	22	9	number	number	NN
work_il2ytikkcvhktlpwxw46dgflri	22	10	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	22	11	antigen	antigen	NN
work_il2ytikkcvhktlpwxw46dgflri	22	12	mismatches	mismatch	NNS
work_il2ytikkcvhktlpwxw46dgflri	22	13	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	22	14	A	a	NN
work_il2ytikkcvhktlpwxw46dgflri	22	15	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	22	16	B	B	NNP
work_il2ytikkcvhktlpwxw46dgflri	22	17	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	22	18	Cw	Cw	NNP
work_il2ytikkcvhktlpwxw46dgflri	22	19	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	22	20	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	22	21	DRB1	DRB1	NNPS
work_il2ytikkcvhktlpwxw46dgflri	22	22	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	22	23	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	22	24	GVH	GVH	NNP
work_il2ytikkcvhktlpwxw46dgflri	22	25	direction	direction	NN
work_il2ytikkcvhktlpwxw46dgflri	22	26	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	23	1	There	there	EX
work_il2ytikkcvhktlpwxw46dgflri	23	2	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	23	3	no	no	DT
work_il2ytikkcvhktlpwxw46dgflri	23	4	discern-	discern-	JJ
work_il2ytikkcvhktlpwxw46dgflri	23	5	able	able	JJ
work_il2ytikkcvhktlpwxw46dgflri	23	6	differences	difference	NNS
work_il2ytikkcvhktlpwxw46dgflri	23	7	based	base	VBN
work_il2ytikkcvhktlpwxw46dgflri	23	8	on	on	IN
work_il2ytikkcvhktlpwxw46dgflri	23	9	degree	degree	NN
work_il2ytikkcvhktlpwxw46dgflri	23	10	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	23	11	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	23	12	disparity	disparity	NN
work_il2ytikkcvhktlpwxw46dgflri	23	13	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	23	14	even	even	RB
work_il2ytikkcvhktlpwxw46dgflri	23	15	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	23	16	most	most	JJS
work_il2ytikkcvhktlpwxw46dgflri	23	17	haplodisparate	haplodisparate	NN
work_il2ytikkcvhktlpwxw46dgflri	23	18	group	group	NN
work_il2ytikkcvhktlpwxw46dgflri	23	19	exhibiting	exhibit	VBG
work_il2ytikkcvhktlpwxw46dgflri	23	20	high	high	JJ
work_il2ytikkcvhktlpwxw46dgflri	23	21	rates	rate	NNS
work_il2ytikkcvhktlpwxw46dgflri	23	22	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	23	23	relapse	relapse	NN
work_il2ytikkcvhktlpwxw46dgflri	23	24	when	when	WRB
work_il2ytikkcvhktlpwxw46dgflri	23	25	disease	disease	NN
work_il2ytikkcvhktlpwxw46dgflri	23	26	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	23	27	present	present	JJ
work_il2ytikkcvhktlpwxw46dgflri	23	28	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	23	29	HSCT	HSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	23	30	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	24	1	In	in	IN
work_il2ytikkcvhktlpwxw46dgflri	24	2	contrast	contrast	NN
work_il2ytikkcvhktlpwxw46dgflri	24	3	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	24	4	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	24	5	presence	presence	NN
work_il2ytikkcvhktlpwxw46dgflri	24	6	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	24	7	active	active	JJ
work_il2ytikkcvhktlpwxw46dgflri	24	8	leukemia	leukemia	NN
work_il2ytikkcvhktlpwxw46dgflri	24	9	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	24	10	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	24	11	time	time	NN
work_il2ytikkcvhktlpwxw46dgflri	24	12	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	24	13	HSCT	HSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	24	14	had	have	VBD
work_il2ytikkcvhktlpwxw46dgflri	24	15	far	far	RB
work_il2ytikkcvhktlpwxw46dgflri	24	16	more	more	JJR
work_il2ytikkcvhktlpwxw46dgflri	24	17	impact	impact	NN
work_il2ytikkcvhktlpwxw46dgflri	24	18	on	on	IN
work_il2ytikkcvhktlpwxw46dgflri	24	19	subsequent	subsequent	JJ
work_il2ytikkcvhktlpwxw46dgflri	24	20	relapse	relapse	NN
work_il2ytikkcvhktlpwxw46dgflri	24	21	rates	rate	NNS
work_il2ytikkcvhktlpwxw46dgflri	24	22	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	24	23	see	see	VB
work_il2ytikkcvhktlpwxw46dgflri	24	24	Table	table	NN
work_il2ytikkcvhktlpwxw46dgflri	24	25	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	24	26	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	25	1	Table	table	NN
work_il2ytikkcvhktlpwxw46dgflri	25	2	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	25	3	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	26	1	Outcomes	outcome	NNS
work_il2ytikkcvhktlpwxw46dgflri	26	2	Based	base	VBN
work_il2ytikkcvhktlpwxw46dgflri	26	3	on	on	IN
work_il2ytikkcvhktlpwxw46dgflri	26	4	Degree	Degree	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	5	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	26	6	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	7	Disparity	Disparity	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	8	4	4	CD
work_il2ytikkcvhktlpwxw46dgflri	26	9	Antigen	Antigen	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	10	3	3	CD
work_il2ytikkcvhktlpwxw46dgflri	26	11	Antigen	Antigen	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	12	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	26	13	Antigen	Antigen	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	14	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	26	15	Antigen	Antigen	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	16	Mismatch	Mismatch	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	17	Mismatch	Mismatch	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	18	Mismatch	Mismatch	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	19	Mismatch	Mismatch	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	20	Number	Number	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	21	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	26	22	Patients	Patients	NNPS
work_il2ytikkcvhktlpwxw46dgflri	26	23	Relapsed/	relapsed/	NN
work_il2ytikkcvhktlpwxw46dgflri	26	24	Total	total	JJ
work_il2ytikkcvhktlpwxw46dgflri	26	25	Relapsed/	relapsed/	NN
work_il2ytikkcvhktlpwxw46dgflri	26	26	Total	total	JJ
work_il2ytikkcvhktlpwxw46dgflri	26	27	Relapsed/	relapsed/	NN
work_il2ytikkcvhktlpwxw46dgflri	26	28	Total	total	JJ
work_il2ytikkcvhktlpwxw46dgflri	26	29	Relapsed/	relapsed/	NN
work_il2ytikkcvhktlpwxw46dgflri	26	30	Total	Total	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	31	Active	active	JJ
work_il2ytikkcvhktlpwxw46dgflri	26	32	Disease	Disease	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	33	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	26	34	HSCT	HSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	35	17	17	CD
work_il2ytikkcvhktlpwxw46dgflri	26	36	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	37	50	50	CD
work_il2ytikkcvhktlpwxw46dgflri	26	38	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	39	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	40	10/12	10/12	CD
work_il2ytikkcvhktlpwxw46dgflri	26	41	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	42	83	83	CD
work_il2ytikkcvhktlpwxw46dgflri	26	43	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	44	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	45	2/2	2/2	CD
work_il2ytikkcvhktlpwxw46dgflri	26	46	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	47	100	100	CD
work_il2ytikkcvhktlpwxw46dgflri	26	48	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	49	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	50	3/3	3/3	CD
work_il2ytikkcvhktlpwxw46dgflri	26	51	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	52	100	100	CD
work_il2ytikkcvhktlpwxw46dgflri	26	53	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	54	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	55	N	n	NN
work_il2ytikkcvhktlpwxw46dgflri	26	56	/	/	SYM
work_il2ytikkcvhktlpwxw46dgflri	26	57	A	A	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	58	CR	CR	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	59	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	26	60	HSCT	HSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	26	61	17	17	CD
work_il2ytikkcvhktlpwxw46dgflri	26	62	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	63	50	50	CD
work_il2ytikkcvhktlpwxw46dgflri	26	64	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	65	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	66	3/9	3/9	CD
work_il2ytikkcvhktlpwxw46dgflri	26	67	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	68	33	33	CD
work_il2ytikkcvhktlpwxw46dgflri	26	69	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	70	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	71	1/7	1/7	CD
work_il2ytikkcvhktlpwxw46dgflri	26	72	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	73	14	14	CD
work_il2ytikkcvhktlpwxw46dgflri	26	74	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	75	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	76	N	n	NN
work_il2ytikkcvhktlpwxw46dgflri	26	77	/	/	SYM
work_il2ytikkcvhktlpwxw46dgflri	26	78	A	a	NN
work_il2ytikkcvhktlpwxw46dgflri	26	79	0/1	0/1	CD
work_il2ytikkcvhktlpwxw46dgflri	26	80	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	81	0	0	CD
work_il2ytikkcvhktlpwxw46dgflri	26	82	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	83	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	84	Total	total	JJ
work_il2ytikkcvhktlpwxw46dgflri	26	85	13/21	13/21	CD
work_il2ytikkcvhktlpwxw46dgflri	26	86	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	87	62	62	CD
work_il2ytikkcvhktlpwxw46dgflri	26	88	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	89	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	90	3/9	3/9	CD
work_il2ytikkcvhktlpwxw46dgflri	26	91	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	92	33	33	CD
work_il2ytikkcvhktlpwxw46dgflri	26	93	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	94	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	95	3/3	3/3	CD
work_il2ytikkcvhktlpwxw46dgflri	26	96	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	97	100	100	CD
work_il2ytikkcvhktlpwxw46dgflri	26	98	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	99	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	100	0/1	0/1	CD
work_il2ytikkcvhktlpwxw46dgflri	26	101	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	26	102	0	0	CD
work_il2ytikkcvhktlpwxw46dgflri	26	103	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	26	104	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	26	105	We	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	26	106	also	also	RB
work_il2ytikkcvhktlpwxw46dgflri	26	107	examined	examine	VBD
work_il2ytikkcvhktlpwxw46dgflri	26	108	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	26	109	impact	impact	NN
work_il2ytikkcvhktlpwxw46dgflri	26	110	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	26	111	immune	immune	JJ
work_il2ytikkcvhktlpwxw46dgflri	26	112	recovery	recovery	NN
work_il2ytikkcvhktlpwxw46dgflri	26	113	on	on	IN
work_il2ytikkcvhktlpwxw46dgflri	26	114	relapse	relapse	NN
work_il2ytikkcvhktlpwxw46dgflri	26	115	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	27	1	Ab-	Ab-	NNP
work_il2ytikkcvhktlpwxw46dgflri	27	2	solute	solute	NN
work_il2ytikkcvhktlpwxw46dgflri	27	3	numbers	number	NNS
work_il2ytikkcvhktlpwxw46dgflri	27	4	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	27	5	NK	NK	NNP
work_il2ytikkcvhktlpwxw46dgflri	27	6	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	27	7	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	27	8	CD4	CD4	NNP
work_il2ytikkcvhktlpwxw46dgflri	27	9	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	27	10	CD8	CD8	NNP
work_il2ytikkcvhktlpwxw46dgflri	27	11	T	T	NNP
work_il2ytikkcvhktlpwxw46dgflri	27	12	cells	cell	NNS
work_il2ytikkcvhktlpwxw46dgflri	27	13	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	27	14	examined	examine	VBN
work_il2ytikkcvhktlpwxw46dgflri	27	15	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	27	16	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	27	17	first	first	JJ
work_il2ytikkcvhktlpwxw46dgflri	27	18	4	4	CD
work_il2ytikkcvhktlpwxw46dgflri	27	19	months	month	NNS
work_il2ytikkcvhktlpwxw46dgflri	27	20	post	post	NN
work_il2ytikkcvhktlpwxw46dgflri	27	21	HSCT	HSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	27	22	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	28	1	T	T	NNP
work_il2ytikkcvhktlpwxw46dgflri	28	2	cell	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	28	3	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	28	4	MNC	MNC	NNP
work_il2ytikkcvhktlpwxw46dgflri	28	5	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	28	6	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	28	7	total	total	JJ
work_il2ytikkcvhktlpwxw46dgflri	28	8	chimerism	chimerism	NN
work_il2ytikkcvhktlpwxw46dgflri	28	9	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	28	10	greater	great	JJR
work_il2ytikkcvhktlpwxw46dgflri	28	11	than	than	IN
work_il2ytikkcvhktlpwxw46dgflri	28	12	99	99	CD
work_il2ytikkcvhktlpwxw46dgflri	28	13	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	28	14	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	28	15	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	28	16	derived	derive	VBN
work_il2ytikkcvhktlpwxw46dgflri	28	17	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	28	18	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	28	19	time	time	NN
work_il2ytikkcvhktlpwxw46dgflri	28	20	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	28	21	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	28	22	assessment	assessment	NN
work_il2ytikkcvhktlpwxw46dgflri	28	23	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	29	1	For	for	IN
work_il2ytikkcvhktlpwxw46dgflri	29	2	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	29	3	who	who	WP
work_il2ytikkcvhktlpwxw46dgflri	29	4	did	do	VBD
work_il2ytikkcvhktlpwxw46dgflri	29	5	or	or	CC
work_il2ytikkcvhktlpwxw46dgflri	29	6	did	do	VBD
work_il2ytikkcvhktlpwxw46dgflri	29	7	not	not	RB
work_il2ytikkcvhktlpwxw46dgflri	29	8	relapse	relapse	VB
work_il2ytikkcvhktlpwxw46dgflri	29	9	post	post	NN
work_il2ytikkcvhktlpwxw46dgflri	29	10	HSCT	HSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	29	11	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	29	12	median	median	JJ
work_il2ytikkcvhktlpwxw46dgflri	29	13	numbers	number	NNS
work_il2ytikkcvhktlpwxw46dgflri	29	14	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	29	15	lymphoid	lymphoid	JJ
work_il2ytikkcvhktlpwxw46dgflri	29	16	subsets	subset	NNS
work_il2ytikkcvhktlpwxw46dgflri	29	17	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	29	18	cells	cell	NNS
work_il2ytikkcvhktlpwxw46dgflri	29	19	/	/	SYM
work_il2ytikkcvhktlpwxw46dgflri	29	20	uL	uL	NNP
work_il2ytikkcvhktlpwxw46dgflri	29	21	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	29	22	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	29	23	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	29	24	NK	NK	NNP
work_il2ytikkcvhktlpwxw46dgflri	29	25	165	165	CD
work_il2ytikkcvhktlpwxw46dgflri	29	26	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	29	27	77	77	CD
work_il2ytikkcvhktlpwxw46dgflri	29	28	-	-	SYM
work_il2ytikkcvhktlpwxw46dgflri	29	29	700	700	CD
work_il2ytikkcvhktlpwxw46dgflri	29	30	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	29	31	vs	vs	IN
work_il2ytikkcvhktlpwxw46dgflri	29	32	209	209	CD
work_il2ytikkcvhktlpwxw46dgflri	29	33	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	29	34	77	77	CD
work_il2ytikkcvhktlpwxw46dgflri	29	35	-	-	SYM
work_il2ytikkcvhktlpwxw46dgflri	29	36	660	660	CD
work_il2ytikkcvhktlpwxw46dgflri	29	37	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	29	38	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	29	39	CD4	CD4	NNP
work_il2ytikkcvhktlpwxw46dgflri	29	40	105	105	CD
work_il2ytikkcvhktlpwxw46dgflri	29	41	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	29	42	18	18	CD
work_il2ytikkcvhktlpwxw46dgflri	29	43	-	-	SYM
work_il2ytikkcvhktlpwxw46dgflri	29	44	245	245	CD
work_il2ytikkcvhktlpwxw46dgflri	29	45	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	29	46	vs	vs	IN
work_il2ytikkcvhktlpwxw46dgflri	29	47	98	98	CD
work_il2ytikkcvhktlpwxw46dgflri	29	48	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	29	49	10	10	CD
work_il2ytikkcvhktlpwxw46dgflri	29	50	-	-	SYM
work_il2ytikkcvhktlpwxw46dgflri	29	51	403	403	CD
work_il2ytikkcvhktlpwxw46dgflri	29	52	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	29	53	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	29	54	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	29	55	CD8	CD8	NNP
work_il2ytikkcvhktlpwxw46dgflri	29	56	82	82	CD
work_il2ytikkcvhktlpwxw46dgflri	29	57	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	29	58	9	9	CD
work_il2ytikkcvhktlpwxw46dgflri	29	59	-	-	SYM
work_il2ytikkcvhktlpwxw46dgflri	29	60	1039	1039	CD
work_il2ytikkcvhktlpwxw46dgflri	29	61	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	29	62	vs	vs	IN
work_il2ytikkcvhktlpwxw46dgflri	29	63	176	176	CD
work_il2ytikkcvhktlpwxw46dgflri	29	64	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	29	65	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	29	66	-	-	SYM
work_il2ytikkcvhktlpwxw46dgflri	29	67	2380	2380	CD
work_il2ytikkcvhktlpwxw46dgflri	29	68	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	29	69	respectively	respectively	RB
work_il2ytikkcvhktlpwxw46dgflri	29	70	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	30	1	In	in	IN
work_il2ytikkcvhktlpwxw46dgflri	30	2	this	this	DT
work_il2ytikkcvhktlpwxw46dgflri	30	3	small	small	JJ
work_il2ytikkcvhktlpwxw46dgflri	30	4	series	series	NN
work_il2ytikkcvhktlpwxw46dgflri	30	5	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	30	6	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	30	7	treated	treat	VBN
work_il2ytikkcvhktlpwxw46dgflri	30	8	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	30	9	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	30	10	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	30	11	step	step	NN
work_il2ytikkcvhktlpwxw46dgflri	30	12	transplant	transplant	NN
work_il2ytikkcvhktlpwxw46dgflri	30	13	method	method	NN
work_il2ytikkcvhktlpwxw46dgflri	30	14	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	30	15	relapse	relapse	NNP
work_il2ytikkcvhktlpwxw46dgflri	30	16	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	30	17	associated	associate	VBN
work_il2ytikkcvhktlpwxw46dgflri	30	18	more	more	RBR
work_il2ytikkcvhktlpwxw46dgflri	30	19	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	30	20	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	30	21	presence	presence	NN
work_il2ytikkcvhktlpwxw46dgflri	30	22	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	30	23	disease	disease	NN
work_il2ytikkcvhktlpwxw46dgflri	30	24	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	30	25	HSCT	HSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	30	26	than	than	IN
work_il2ytikkcvhktlpwxw46dgflri	30	27	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	30	28	any	any	DT
work_il2ytikkcvhktlpwxw46dgflri	30	29	discern-	discern-	JJ
work_il2ytikkcvhktlpwxw46dgflri	30	30	able	able	JJ
work_il2ytikkcvhktlpwxw46dgflri	30	31	trend	trend	NN
work_il2ytikkcvhktlpwxw46dgflri	30	32	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	30	33	degree	degree	NN
work_il2ytikkcvhktlpwxw46dgflri	30	34	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	30	35	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	30	36	disparity	disparity	NN
work_il2ytikkcvhktlpwxw46dgflri	30	37	or	or	CC
work_il2ytikkcvhktlpwxw46dgflri	30	38	early	early	JJ
work_il2ytikkcvhktlpwxw46dgflri	30	39	immunologic	immunologic	JJ
work_il2ytikkcvhktlpwxw46dgflri	30	40	recov-	recov-	NN
work_il2ytikkcvhktlpwxw46dgflri	30	41	ery	ery	NN
work_il2ytikkcvhktlpwxw46dgflri	30	42	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	31	1	Other	other	JJ
work_il2ytikkcvhktlpwxw46dgflri	31	2	approaches	approach	NNS
work_il2ytikkcvhktlpwxw46dgflri	31	3	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	31	4	treat	treat	VB
work_il2ytikkcvhktlpwxw46dgflri	31	5	resistant	resistant	JJ
work_il2ytikkcvhktlpwxw46dgflri	31	6	leukemia	leukemia	NN
work_il2ytikkcvhktlpwxw46dgflri	31	7	are	be	VBP
work_il2ytikkcvhktlpwxw46dgflri	31	8	required	require	VBN
work_il2ytikkcvhktlpwxw46dgflri	31	9	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	31	10	substantially	substantially	RB
work_il2ytikkcvhktlpwxw46dgflri	31	11	improve	improve	VB
work_il2ytikkcvhktlpwxw46dgflri	31	12	disease	disease	NN
work_il2ytikkcvhktlpwxw46dgflri	31	13	free	free	JJ
work_il2ytikkcvhktlpwxw46dgflri	31	14	survival	survival	NN
work_il2ytikkcvhktlpwxw46dgflri	31	15	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	31	16	these	these	DT
work_il2ytikkcvhktlpwxw46dgflri	31	17	high	high	JJ
work_il2ytikkcvhktlpwxw46dgflri	31	18	risk	risk	NN
work_il2ytikkcvhktlpwxw46dgflri	31	19	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	31	20	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	32	1	197	197	CD
work_il2ytikkcvhktlpwxw46dgflri	32	2	ANTI	anti	JJ
work_il2ytikkcvhktlpwxw46dgflri	32	3	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	32	4	HLA	hla	JJ
work_il2ytikkcvhktlpwxw46dgflri	32	5	ANTIBODIES	ANTIBODIES	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	6	PREDICT	predict	NN
work_il2ytikkcvhktlpwxw46dgflri	32	7	GRAFT	GRAFT	NNS
work_il2ytikkcvhktlpwxw46dgflri	32	8	FAILURE	FAILURE	NNS
work_il2ytikkcvhktlpwxw46dgflri	32	9	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	10	TIME	TIME	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	11	TO	to	IN
work_il2ytikkcvhktlpwxw46dgflri	32	12	ENGRAFT-	ENGRAFT-	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	13	MENT	MENT	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	14	AND	and	CC
work_il2ytikkcvhktlpwxw46dgflri	32	15	UMBILICAL	UMBILICAL	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	16	CORD	cord	NN
work_il2ytikkcvhktlpwxw46dgflri	32	17	UNIT	UNIT	NNS
work_il2ytikkcvhktlpwxw46dgflri	32	18	DOMINANCE	dominance	NN
work_il2ytikkcvhktlpwxw46dgflri	32	19	IN	in	IN
work_il2ytikkcvhktlpwxw46dgflri	32	20	DOUBLE	DOUBLE	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	21	UMBILICAL	umbilical	NN
work_il2ytikkcvhktlpwxw46dgflri	32	22	CORD	cord	NN
work_il2ytikkcvhktlpwxw46dgflri	32	23	BLOOD	blood	NN
work_il2ytikkcvhktlpwxw46dgflri	32	24	TRANSPLANTATION	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	32	25	Cutler	Cutler	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	26	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	27	C.1	C.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	28	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	29	Kim	Kim	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	30	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	31	H.T.2	H.T.2	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	32	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	33	Sun	Sun	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	34	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	35	L.2	L.2	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	36	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	37	Sese	Sese	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	38	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	39	D.3	D.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	40	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	41	Kao	Kao	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	42	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	43	G.1	G.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	44	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	45	Vasquez	Vasquez	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	46	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	47	M.1	M.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	48	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	49	Armand	Armand	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	50	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	51	P.1	P.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	52	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	53	Koreth	Koreth	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	54	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	55	J.1	J.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	56	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	57	Ho	Ho	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	58	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	59	V.T.1	V.T.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	60	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	61	Alyea	Alyea	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	62	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	63	E.1	E.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	64	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	65	Soiffer	Soiffer	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	66	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	67	R.J.1	R.J.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	68	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	69	Ballen	Ballen	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	70	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	71	K.1	K.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	72	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	73	Ritz	Ritz	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	74	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	75	J.1	J.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	76	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	77	Milford	Milford	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	78	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	79	E.3	E.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	80	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	81	Antin	Antin	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	82	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	83	J.H.1	J.H.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	84	1Dana	1Dana	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	85	-	-	:
work_il2ytikkcvhktlpwxw46dgflri	32	86	Farber	Farber	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	87	Cancer	Cancer	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	88	Institute	Institute	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	89	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	90	Boston	Boston	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	91	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	92	MA	MA	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	93	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	32	94	2Dana	2Dana	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	95	-	-	:
work_il2ytikkcvhktlpwxw46dgflri	32	96	Farber	Farber	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	97	Cancer	Cancer	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	98	Institute	Institute	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	99	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	100	Boston	Boston	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	101	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	102	MA	MA	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	103	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	32	104	3Brigham	3Brigham	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	105	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	32	106	Women	Women	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	107	’s	’s	POS
work_il2ytikkcvhktlpwxw46dgflri	32	108	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	109	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	110	Boston	Boston	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	111	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	32	112	MA	MA	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	113	Anti	Anti	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	114	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	32	115	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	116	antibodies	antibody	NNS
work_il2ytikkcvhktlpwxw46dgflri	32	117	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	32	118	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	119	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	32	120	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	121	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	32	122	predict	predict	VB
work_il2ytikkcvhktlpwxw46dgflri	32	123	graft	graft	NN
work_il2ytikkcvhktlpwxw46dgflri	32	124	failure	failure	NN
work_il2ytikkcvhktlpwxw46dgflri	32	125	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	32	126	unrelated	unrelated	JJ
work_il2ytikkcvhktlpwxw46dgflri	32	127	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	32	128	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	32	129	single	single	JJ
work_il2ytikkcvhktlpwxw46dgflri	32	130	umbilical	umbilical	JJ
work_il2ytikkcvhktlpwxw46dgflri	32	131	cord	cord	NN
work_il2ytikkcvhktlpwxw46dgflri	32	132	blood	blood	NN
work_il2ytikkcvhktlpwxw46dgflri	32	133	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	32	134	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	32	135	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	32	136	transplantation	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	32	137	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	33	1	We	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	33	2	measured	measure	VBD
work_il2ytikkcvhktlpwxw46dgflri	33	3	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	33	4	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	33	5	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	33	6	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	33	7	double	double	JJ
work_il2ytikkcvhktlpwxw46dgflri	33	8	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	33	9	transplantation	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	33	10	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	33	11	DUCBT	DUCBT	NNP
work_il2ytikkcvhktlpwxw46dgflri	33	12	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	33	13	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	33	14	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	33	15	hypothesis	hypothesis	NN
work_il2ytikkcvhktlpwxw46dgflri	33	16	that	that	IN
work_il2ytikkcvhktlpwxw46dgflri	33	17	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	33	18	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	33	19	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	33	20	would	would	MD
work_il2ytikkcvhktlpwxw46dgflri	33	21	predict	predict	VB
work_il2ytikkcvhktlpwxw46dgflri	33	22	time	time	NN
work_il2ytikkcvhktlpwxw46dgflri	33	23	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	33	24	engraftment	engraftment	VB
work_il2ytikkcvhktlpwxw46dgflri	33	25	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	33	26	graft	graft	NN
work_il2ytikkcvhktlpwxw46dgflri	33	27	failure	failure	NN
work_il2ytikkcvhktlpwxw46dgflri	33	28	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	33	29	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	33	30	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	33	31	dominance	dominance	NN
work_il2ytikkcvhktlpwxw46dgflri	33	32	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	34	1	Methods	method	NNS
work_il2ytikkcvhktlpwxw46dgflri	34	2	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	34	3	73	73	CD
work_il2ytikkcvhktlpwxw46dgflri	34	4	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	34	5	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	34	6	banked	banked	JJ
work_il2ytikkcvhktlpwxw46dgflri	34	7	pre	pre	JJ
work_il2ytikkcvhktlpwxw46dgflri	34	8	-	-	JJ
work_il2ytikkcvhktlpwxw46dgflri	34	9	transplant	transplant	JJ
work_il2ytikkcvhktlpwxw46dgflri	34	10	sera	sera	NN
work_il2ytikkcvhktlpwxw46dgflri	34	11	who	who	WP
work_il2ytikkcvhktlpwxw46dgflri	34	12	under-	under-	VBZ
work_il2ytikkcvhktlpwxw46dgflri	34	13	went	go	VBD
work_il2ytikkcvhktlpwxw46dgflri	34	14	DUCBT	DUCBT	NNP
work_il2ytikkcvhktlpwxw46dgflri	34	15	using	use	VBG
work_il2ytikkcvhktlpwxw46dgflri	34	16	4/6	4/6	CD
work_il2ytikkcvhktlpwxw46dgflri	34	17	or	or	CC
work_il2ytikkcvhktlpwxw46dgflri	34	18	better	well	JJR
work_il2ytikkcvhktlpwxw46dgflri	34	19	allelic	allelic	JJ
work_il2ytikkcvhktlpwxw46dgflri	34	20	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	34	21	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	34	22	matched	match	VBN
work_il2ytikkcvhktlpwxw46dgflri	34	23	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	34	24	units	unit	NNS
work_il2ytikkcvhktlpwxw46dgflri	34	25	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	34	26	2004	2004	CD
work_il2ytikkcvhktlpwxw46dgflri	34	27	-2008	-2008	NNP
work_il2ytikkcvhktlpwxw46dgflri	34	28	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	34	29	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	34	30	studied	study	VBN
work_il2ytikkcvhktlpwxw46dgflri	34	31	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	35	1	Labscreen	Labscreen	NNP
work_il2ytikkcvhktlpwxw46dgflri	35	2	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	35	3	One	one	CD
work_il2ytikkcvhktlpwxw46dgflri	35	4	Lambda	Lambda	NNP
work_il2ytikkcvhktlpwxw46dgflri	35	5	Inc.	Inc.	NNP
work_il2ytikkcvhktlpwxw46dgflri	35	6	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	35	7	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	35	8	used	use	VBN
work_il2ytikkcvhktlpwxw46dgflri	35	9	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	35	10	capture	capture	VB
work_il2ytikkcvhktlpwxw46dgflri	35	11	class	class	NN
work_il2ytikkcvhktlpwxw46dgflri	35	12	I	i	NN
work_il2ytikkcvhktlpwxw46dgflri	35	13	/	/	SYM
work_il2ytikkcvhktlpwxw46dgflri	35	14	II	II	NNP
work_il2ytikkcvhktlpwxw46dgflri	35	15	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	35	16	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	35	17	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	35	18	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	35	19	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	35	20	Luminex100	Luminex100	NNP
work_il2ytikkcvhktlpwxw46dgflri	35	21	IS	IS	NNP
work_il2ytikkcvhktlpwxw46dgflri	35	22	system	system	NN
work_il2ytikkcvhktlpwxw46dgflri	35	23	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	35	24	used	use	VBN
work_il2ytikkcvhktlpwxw46dgflri	35	25	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	35	26	detect	detect	VB
work_il2ytikkcvhktlpwxw46dgflri	35	27	fluorescent	fluorescent	NN
work_il2ytikkcvhktlpwxw46dgflri	35	28	tagged	tag	VBN
work_il2ytikkcvhktlpwxw46dgflri	35	29	binding	binding	NN
work_il2ytikkcvhktlpwxw46dgflri	35	30	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	35	31	human	human	JJ
work_il2ytikkcvhktlpwxw46dgflri	35	32	IgG.	IgG.	NNP
work_il2ytikkcvhktlpwxw46dgflri	36	1	Visual	visual	JJ
work_il2ytikkcvhktlpwxw46dgflri	36	2	software	software	NN
work_il2ytikkcvhktlpwxw46dgflri	36	3	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	36	4	used	use	VBN
work_il2ytikkcvhktlpwxw46dgflri	36	5	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	36	6	normalize	normalize	VB
work_il2ytikkcvhktlpwxw46dgflri	36	7	results	result	NNS
work_il2ytikkcvhktlpwxw46dgflri	36	8	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	36	9	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	36	10	deter-	deter-	VB
work_il2ytikkcvhktlpwxw46dgflri	36	11	mine	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	36	12	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	36	13	presence	presence	NN
work_il2ytikkcvhktlpwxw46dgflri	36	14	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	36	15	mixed	mixed	JJ
work_il2ytikkcvhktlpwxw46dgflri	36	16	class	class	NN
work_il2ytikkcvhktlpwxw46dgflri	36	17	I	i	NN
work_il2ytikkcvhktlpwxw46dgflri	36	18	/	/	SYM
work_il2ytikkcvhktlpwxw46dgflri	36	19	II	II	NNP
work_il2ytikkcvhktlpwxw46dgflri	36	20	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	36	21	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	36	22	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	36	23	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	37	1	Positive	positive	JJ
work_il2ytikkcvhktlpwxw46dgflri	37	2	samples	sample	NNS
work_il2ytikkcvhktlpwxw46dgflri	37	3	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	37	4	tested	test	VBN
work_il2ytikkcvhktlpwxw46dgflri	37	5	using	use	VBG
work_il2ytikkcvhktlpwxw46dgflri	37	6	single	single	JJ
work_il2ytikkcvhktlpwxw46dgflri	37	7	antigen	antigen	NN
work_il2ytikkcvhktlpwxw46dgflri	37	8	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	37	9	coated	coat	VBN
work_il2ytikkcvhktlpwxw46dgflri	37	10	microbeads	microbead	NNS
work_il2ytikkcvhktlpwxw46dgflri	37	11	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	38	1	Beads	bead	NNS
work_il2ytikkcvhktlpwxw46dgflri	38	2	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	38	3	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	38	4	1000	1000	CD
work_il2ytikkcvhktlpwxw46dgflri	38	5	mean	mean	JJ
work_il2ytikkcvhktlpwxw46dgflri	38	6	fluorescent	fluorescent	JJ
work_il2ytikkcvhktlpwxw46dgflri	38	7	intensity	intensity	NN
work_il2ytikkcvhktlpwxw46dgflri	38	8	above	above	IN
work_il2ytikkcvhktlpwxw46dgflri	38	9	baseline	baseline	NNP
work_il2ytikkcvhktlpwxw46dgflri	38	10	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	38	11	considered	consider	VBN
work_il2ytikkcvhktlpwxw46dgflri	38	12	positive	positive	JJ
work_il2ytikkcvhktlpwxw46dgflri	38	13	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	39	1	Chimerism	chimerism	NN
work_il2ytikkcvhktlpwxw46dgflri	39	2	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	39	3	measured	measure	VBN
work_il2ytikkcvhktlpwxw46dgflri	39	4	using	use	VBG
work_il2ytikkcvhktlpwxw46dgflri	39	5	STR	STR	NNP
work_il2ytikkcvhktlpwxw46dgflri	39	6	typing	type	VBG
work_il2ytikkcvhktlpwxw46dgflri	39	7	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	39	8	informa-	informa-	JJ
work_il2ytikkcvhktlpwxw46dgflri	39	9	tive	tive	JJ
work_il2ytikkcvhktlpwxw46dgflri	39	10	alleles	allele	NNS
work_il2ytikkcvhktlpwxw46dgflri	39	11	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	40	1	Graft	graft	NN
work_il2ytikkcvhktlpwxw46dgflri	40	2	failure	failure	NN
work_il2ytikkcvhktlpwxw46dgflri	40	3	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	40	4	defined	define	VBN
work_il2ytikkcvhktlpwxw46dgflri	40	5	as	as	IN
work_il2ytikkcvhktlpwxw46dgflri	40	6	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	40	7	absence	absence	NN
work_il2ytikkcvhktlpwxw46dgflri	40	8	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	40	9	neutrophil	neutrophil	NNP
work_il2ytikkcvhktlpwxw46dgflri	40	10	engraftment	engraftment	NN
work_il2ytikkcvhktlpwxw46dgflri	40	11	42	42	CD
work_il2ytikkcvhktlpwxw46dgflri	40	12	days	day	NNS
work_il2ytikkcvhktlpwxw46dgflri	40	13	from	from	IN
work_il2ytikkcvhktlpwxw46dgflri	40	14	DUCBT	ducbt	NN
work_il2ytikkcvhktlpwxw46dgflri	40	15	or	or	CC
work_il2ytikkcvhktlpwxw46dgflri	40	16	loss	loss	NN
work_il2ytikkcvhktlpwxw46dgflri	40	17	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	40	18	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	40	19	chimerism	chimerism	NN
work_il2ytikkcvhktlpwxw46dgflri	40	20	by	by	IN
work_il2ytikkcvhktlpwxw46dgflri	40	21	day	day	NN
work_il2ytikkcvhktlpwxw46dgflri	40	22	100	100	CD
work_il2ytikkcvhktlpwxw46dgflri	40	23	without	without	IN
work_il2ytikkcvhktlpwxw46dgflri	40	24	malignant	malignant	JJ
work_il2ytikkcvhktlpwxw46dgflri	40	25	relapse	relapse	NN
work_il2ytikkcvhktlpwxw46dgflri	40	26	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	41	1	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	41	2	dominance	dominance	NN
work_il2ytikkcvhktlpwxw46dgflri	41	3	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	41	4	defined	define	VBN
work_il2ytikkcvhktlpwxw46dgflri	41	5	as	as	IN
work_il2ytikkcvhktlpwxw46dgflri	41	6	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	42	1	90	90	CD
work_il2ytikkcvhktlpwxw46dgflri	42	2	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	42	3	contribution	contribution	NN
work_il2ytikkcvhktlpwxw46dgflri	42	4	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	42	5	hematopoiesis	hematopoiesis	NN
work_il2ytikkcvhktlpwxw46dgflri	42	6	by	by	IN
work_il2ytikkcvhktlpwxw46dgflri	42	7	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	42	8	single	single	JJ
work_il2ytikkcvhktlpwxw46dgflri	42	9	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	42	10	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	42	11	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	42	12	day	day	NN
work_il2ytikkcvhktlpwxw46dgflri	42	13	100	100	CD
work_il2ytikkcvhktlpwxw46dgflri	42	14	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	43	1	S226	S226	NNP
work_il2ytikkcvhktlpwxw46dgflri	43	2	Poster	Poster	NNP
work_il2ytikkcvhktlpwxw46dgflri	43	3	Session	Session	NNP
work_il2ytikkcvhktlpwxw46dgflri	43	4	I	I	NNP
work_il2ytikkcvhktlpwxw46dgflri	43	5	Results	result	VBZ
work_il2ytikkcvhktlpwxw46dgflri	43	6	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	43	7	18	18	CD
work_il2ytikkcvhktlpwxw46dgflri	43	8	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	43	9	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	43	10	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	43	11	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	43	12	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	43	13	against	against	IN
work_il2ytikkcvhktlpwxw46dgflri	43	14	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	43	15	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	43	16	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	43	17	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	43	18	9	9	CD
work_il2ytikkcvhktlpwxw46dgflri	43	19	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	43	20	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	43	21	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	43	22	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	43	23	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	43	24	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	43	25	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	43	26	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	43	27	or	or	CC
work_il2ytikkcvhktlpwxw46dgflri	43	28	both	both	CC
work_il2ytikkcvhktlpwxw46dgflri	43	29	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	43	30	units	unit	NNS
work_il2ytikkcvhktlpwxw46dgflri	43	31	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	43	32	7	7	CD
work_il2ytikkcvhktlpwxw46dgflri	43	33	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	43	34	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	43	35	identified	identify	VBN
work_il2ytikkcvhktlpwxw46dgflri	43	36	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	44	1	No	no	DT
work_il2ytikkcvhktlpwxw46dgflri	44	2	differences	difference	NNS
work_il2ytikkcvhktlpwxw46dgflri	44	3	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	44	4	cell	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	44	5	doses	dose	NNS
work_il2ytikkcvhktlpwxw46dgflri	44	6	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	44	7	viability	viability	NN
work_il2ytikkcvhktlpwxw46dgflri	44	8	or	or	CC
work_il2ytikkcvhktlpwxw46dgflri	44	9	baseline	baseline	NN
work_il2ytikkcvhktlpwxw46dgflri	44	10	characteristics	characteristic	NNS
work_il2ytikkcvhktlpwxw46dgflri	44	11	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	44	12	noted	note	VBN
work_il2ytikkcvhktlpwxw46dgflri	44	13	between	between	IN
work_il2ytikkcvhktlpwxw46dgflri	44	14	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	44	15	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	44	16	/	/	SYM
work_il2ytikkcvhktlpwxw46dgflri	44	17	without	without	IN
work_il2ytikkcvhktlpwxw46dgflri	44	18	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	44	19	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	44	20	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	44	21	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	45	1	The	the	DT
work_il2ytikkcvhktlpwxw46dgflri	45	2	presence	presence	NN
work_il2ytikkcvhktlpwxw46dgflri	45	3	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	45	4	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	45	5	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	45	6	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	45	7	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	45	8	asso-	asso-	RB
work_il2ytikkcvhktlpwxw46dgflri	45	9	ciated	ciate	VBN
work_il2ytikkcvhktlpwxw46dgflri	45	10	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	45	11	an	an	DT
work_il2ytikkcvhktlpwxw46dgflri	45	12	increased	increase	VBN
work_il2ytikkcvhktlpwxw46dgflri	45	13	risk	risk	NN
work_il2ytikkcvhktlpwxw46dgflri	45	14	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	45	15	graft	graft	NN
work_il2ytikkcvhktlpwxw46dgflri	45	16	failure	failure	NN
work_il2ytikkcvhktlpwxw46dgflri	45	17	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	45	18	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	45	19	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	45	20	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	45	21	against	against	IN
work_il2ytikkcvhktlpwxw46dgflri	45	22	either	either	CC
work_il2ytikkcvhktlpwxw46dgflri	45	23	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	45	24	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	45	25	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	45	26	OR	or	CC
work_il2ytikkcvhktlpwxw46dgflri	45	27	8.67	8.67	CD
work_il2ytikkcvhktlpwxw46dgflri	45	28	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	45	29	95%CI	95%ci	CD
work_il2ytikkcvhktlpwxw46dgflri	45	30	1.89–39.68	1.89–39.68	CD
work_il2ytikkcvhktlpwxw46dgflri	45	31	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	45	32	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	45	33	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	45	34	0.0055	0.0055	CD
work_il2ytikkcvhktlpwxw46dgflri	45	35	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	45	36	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	45	37	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	45	38	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	45	39	against	against	IN
work_il2ytikkcvhktlpwxw46dgflri	45	40	both	both	CC
work_il2ytikkcvhktlpwxw46dgflri	45	41	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	45	42	units	unit	NNS
work_il2ytikkcvhktlpwxw46dgflri	45	43	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	45	44	OR	or	CC
work_il2ytikkcvhktlpwxw46dgflri	45	45	16.27	16.27	CD
work_il2ytikkcvhktlpwxw46dgflri	45	46	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	45	47	2.82–93.87	2.82–93.87	CD
work_il2ytikkcvhktlpwxw46dgflri	45	48	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	45	49	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	45	50	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	45	51	0.0034	0.0034	CD
work_il2ytikkcvhktlpwxw46dgflri	45	52	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	45	53	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	46	1	Neu-	Neu-	NNP
work_il2ytikkcvhktlpwxw46dgflri	46	2	trophil	trophil	IN
work_il2ytikkcvhktlpwxw46dgflri	46	3	engraftment	engraftment	NN
work_il2ytikkcvhktlpwxw46dgflri	46	4	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	46	5	delayed	delay	VBN
work_il2ytikkcvhktlpwxw46dgflri	46	6	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	46	7	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	46	8	presence	presence	NN
work_il2ytikkcvhktlpwxw46dgflri	46	9	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	46	10	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	46	11	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	46	12	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	46	13	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	46	14	median	median	NNP
work_il2ytikkcvhktlpwxw46dgflri	46	15	21	21	CD
work_il2ytikkcvhktlpwxw46dgflri	46	16	vs.	vs.	IN
work_il2ytikkcvhktlpwxw46dgflri	46	17	29	29	CD
work_il2ytikkcvhktlpwxw46dgflri	46	18	days	day	NNS
work_il2ytikkcvhktlpwxw46dgflri	46	19	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	46	20	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	46	21	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	46	22	0.04	0.04	CD
work_il2ytikkcvhktlpwxw46dgflri	46	23	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	46	24	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	46	25	fewer	few	JJR
work_il2ytikkcvhktlpwxw46dgflri	46	26	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	46	27	engrafted	engraft	VBD
work_il2ytikkcvhktlpwxw46dgflri	46	28	platelets	platelet	NNS
work_il2ytikkcvhktlpwxw46dgflri	46	29	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	46	30	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	46	31	presence	presence	NN
work_il2ytikkcvhktlpwxw46dgflri	46	32	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	46	33	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	46	34	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	46	35	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	46	36	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	46	37	76.4	76.4	CD
work_il2ytikkcvhktlpwxw46dgflri	46	38	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	46	39	vs.	vs.	NN
work_il2ytikkcvhktlpwxw46dgflri	46	40	50	50	CD
work_il2ytikkcvhktlpwxw46dgflri	46	41	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	46	42	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	46	43	p	p	NNP
work_il2ytikkcvhktlpwxw46dgflri	46	44	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	46	45	0.03	0.03	CD
work_il2ytikkcvhktlpwxw46dgflri	46	46	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	46	47	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	47	1	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	47	2	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	47	3	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	47	4	against	against	IN
work_il2ytikkcvhktlpwxw46dgflri	47	5	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	47	6	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	47	7	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	47	8	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	47	9	associated	associate	VBN
work_il2ytikkcvhktlpwxw46dgflri	47	10	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	47	11	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	47	12	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	47	13	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	47	14	dominance	dominance	NN
work_il2ytikkcvhktlpwxw46dgflri	47	15	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	47	16	OR	or	CC
work_il2ytikkcvhktlpwxw46dgflri	47	17	9.43	9.43	CD
work_il2ytikkcvhktlpwxw46dgflri	47	18	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	47	19	95%CI	95%ci	CD
work_il2ytikkcvhktlpwxw46dgflri	47	20	1.16–76.47	1.16–76.47	CD
work_il2ytikkcvhktlpwxw46dgflri	47	21	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	47	22	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	47	23	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	47	24	0.015	0.015	CD
work_il2ytikkcvhktlpwxw46dgflri	47	25	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	47	26	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	47	27	while	while	IN
work_il2ytikkcvhktlpwxw46dgflri	47	28	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	47	29	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	47	30	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	47	31	against	against	IN
work_il2ytikkcvhktlpwxw46dgflri	47	32	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	47	33	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	47	34	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	47	35	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	47	36	associated	associate	VBN
work_il2ytikkcvhktlpwxw46dgflri	47	37	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	47	38	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	47	39	non	non	JJ
work_il2ytikkcvhktlpwxw46dgflri	47	40	-	-	JJ
work_il2ytikkcvhktlpwxw46dgflri	47	41	significant	significant	JJ
work_il2ytikkcvhktlpwxw46dgflri	47	42	trend	trend	NN
work_il2ytikkcvhktlpwxw46dgflri	47	43	toward	toward	IN
work_il2ytikkcvhktlpwxw46dgflri	47	44	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	47	45	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	47	46	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	47	47	dominance	dominance	NN
work_il2ytikkcvhktlpwxw46dgflri	47	48	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	47	49	OR	or	CC
work_il2ytikkcvhktlpwxw46dgflri	47	50	2.70	2.70	CD
work_il2ytikkcvhktlpwxw46dgflri	47	51	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	47	52	95%CI	95%ci	CD
work_il2ytikkcvhktlpwxw46dgflri	47	53	0.63–12.5	0.63–12.5	CD
work_il2ytikkcvhktlpwxw46dgflri	47	54	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	47	55	p	p	NNP
work_il2ytikkcvhktlpwxw46dgflri	47	56	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	47	57	0.28	0.28	CD
work_il2ytikkcvhktlpwxw46dgflri	47	58	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	47	59	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	48	1	Overall	overall	JJ
work_il2ytikkcvhktlpwxw46dgflri	48	2	survival	survival	NN
work_il2ytikkcvhktlpwxw46dgflri	48	3	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	48	4	inferior	inferior	JJ
work_il2ytikkcvhktlpwxw46dgflri	48	5	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	48	6	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	48	7	presence	presence	NN
work_il2ytikkcvhktlpwxw46dgflri	48	8	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	48	9	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	48	10	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	48	11	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	48	12	against	against	IN
work_il2ytikkcvhktlpwxw46dgflri	48	13	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	48	14	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	48	15	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	48	16	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	48	17	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	48	18	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	48	19	0.044	0.044	CD
work_il2ytikkcvhktlpwxw46dgflri	48	20	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	48	21	or	or	CC
work_il2ytikkcvhktlpwxw46dgflri	48	22	both	both	CC
work_il2ytikkcvhktlpwxw46dgflri	48	23	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	48	24	units	unit	NNS
work_il2ytikkcvhktlpwxw46dgflri	48	25	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	48	26	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	48	27	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	48	28	0.027	0.027	CD
work_il2ytikkcvhktlpwxw46dgflri	48	29	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	48	30	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	48	31	but	but	CC
work_il2ytikkcvhktlpwxw46dgflri	48	32	not	not	RB
work_il2ytikkcvhktlpwxw46dgflri	48	33	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	48	34	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	48	35	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	48	36	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	48	37	against	against	IN
work_il2ytikkcvhktlpwxw46dgflri	48	38	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	48	39	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	48	40	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	48	41	only	only	RB
work_il2ytikkcvhktlpwxw46dgflri	48	42	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	49	1	Conclusions	conclusion	NNS
work_il2ytikkcvhktlpwxw46dgflri	49	2	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	49	3	In	in	IN
work_il2ytikkcvhktlpwxw46dgflri	49	4	DUBCT	DUBCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	49	5	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	49	6	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	49	7	presence	presence	NN
work_il2ytikkcvhktlpwxw46dgflri	49	8	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	49	9	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	49	10	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	49	11	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	49	12	increases	increase	VBZ
work_il2ytikkcvhktlpwxw46dgflri	49	13	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	49	14	risk	risk	NN
work_il2ytikkcvhktlpwxw46dgflri	49	15	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	49	16	graft	graft	NN
work_il2ytikkcvhktlpwxw46dgflri	49	17	rejection	rejection	NN
work_il2ytikkcvhktlpwxw46dgflri	49	18	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	49	19	prolongs	prolong	NNS
work_il2ytikkcvhktlpwxw46dgflri	49	20	time	time	NN
work_il2ytikkcvhktlpwxw46dgflri	49	21	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	49	22	engraftment	engraftment	VB
work_il2ytikkcvhktlpwxw46dgflri	49	23	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	49	24	predicts	predict	VBZ
work_il2ytikkcvhktlpwxw46dgflri	49	25	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	49	26	dominance	dominance	NN
work_il2ytikkcvhktlpwxw46dgflri	49	27	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	49	28	is	be	VBZ
work_il2ytikkcvhktlpwxw46dgflri	49	29	associated	associate	VBN
work_il2ytikkcvhktlpwxw46dgflri	49	30	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	49	31	inferior	inferior	JJ
work_il2ytikkcvhktlpwxw46dgflri	49	32	outcome	outcome	NN
work_il2ytikkcvhktlpwxw46dgflri	49	33	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	50	1	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	50	2	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	50	3	Ab	Ab	NNP
work_il2ytikkcvhktlpwxw46dgflri	50	4	screen-	screen-	NN
work_il2ytikkcvhktlpwxw46dgflri	50	5	ing	ing	NNP
work_il2ytikkcvhktlpwxw46dgflri	50	6	should	should	MD
work_il2ytikkcvhktlpwxw46dgflri	50	7	be	be	VB
work_il2ytikkcvhktlpwxw46dgflri	50	8	incorporated	incorporate	VBN
work_il2ytikkcvhktlpwxw46dgflri	50	9	into	into	IN
work_il2ytikkcvhktlpwxw46dgflri	50	10	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	50	11	unit	unit	NN
work_il2ytikkcvhktlpwxw46dgflri	50	12	selection	selection	NN
work_il2ytikkcvhktlpwxw46dgflri	50	13	strategies	strategy	NNS
work_il2ytikkcvhktlpwxw46dgflri	50	14	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	50	15	DUCBT	DUCBT	NNP
work_il2ytikkcvhktlpwxw46dgflri	50	16	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	51	1	198	198	CD
work_il2ytikkcvhktlpwxw46dgflri	51	2	EX	EX	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	3	VIVO	VIVO	VBD
work_il2ytikkcvhktlpwxw46dgflri	51	4	TREATMENT	treatment	NN
work_il2ytikkcvhktlpwxw46dgflri	51	5	OF	of	IN
work_il2ytikkcvhktlpwxw46dgflri	51	6	HEMATOPOIETIC	HEMATOPOIETIC	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	7	STEM	stem	NN
work_il2ytikkcvhktlpwxw46dgflri	51	8	CELLS	cell	NNS
work_il2ytikkcvhktlpwxw46dgflri	51	9	WITH	with	IN
work_il2ytikkcvhktlpwxw46dgflri	51	10	16,16-DI-	16,16-di-	JJ
work_il2ytikkcvhktlpwxw46dgflri	51	11	METHYL	methyl	NN
work_il2ytikkcvhktlpwxw46dgflri	51	12	PROSTAGLANDIN	prostaglandin	NN
work_il2ytikkcvhktlpwxw46dgflri	51	13	E2	e2	NN
work_il2ytikkcvhktlpwxw46dgflri	51	14	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	51	15	FT1050	FT1050	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	16	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	51	17	IMPROVES	improves	FW
work_il2ytikkcvhktlpwxw46dgflri	51	18	ENGRAFTMENT	ENGRAFTMENT	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	19	AND	and	CC
work_il2ytikkcvhktlpwxw46dgflri	51	20	HEMATOPOIETIC	HEMATOPOIETIC	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	21	RECONSTITUTION	RECONSTITUTION	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	22	Cutler	Cutler	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	23	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	24	C.S.1	C.S.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	25	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	26	Desponts	Desponts	NNPS
work_il2ytikkcvhktlpwxw46dgflri	51	27	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	28	C.3	C.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	29	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	30	Robbins	Robbins	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	31	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	32	D.3	D.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	33	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	34	North	North	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	35	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	36	T.E.4	T.E.4	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	37	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	38	Goessling	Goessling	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	39	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	40	W.5	W.5	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	41	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	42	Kao	Kao	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	43	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	44	G.6	G.6	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	45	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	46	Ritz	Ritz	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	47	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	48	J.6	J.6	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	49	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	50	Ballen	Ballen	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	51	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	52	K.K.2	K.K.2	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	53	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	54	Antin	Antin	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	55	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	56	J.H.1	J.H.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	57	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	58	Spitzer	Spitzer	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	59	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	60	T.R.2	T.R.2	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	61	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	62	Soiffer-	Soiffer-	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	63	ChenY.-B.A.	ChenY.-B.A.	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	64	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	65	R.J.1,2	R.J.1,2	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	66	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	67	Ho	Ho	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	68	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	69	V.T.1	V.T.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	70	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	71	Armand	Armand	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	72	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	73	P.1	P.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	74	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	75	Koreth	Koreth	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	76	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	77	J.1	J.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	78	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	79	Alyea	Alyea	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	80	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	81	E.1	E.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	82	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	83	McAfee	McAfee	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	84	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	85	S.2	S.2	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	86	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	87	Dey	Dey	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	88	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	89	B.R.2	B.R.2	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	90	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	91	Shoemaker	Shoemaker	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	92	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	93	D.3	D.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	94	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	95	Multani	Multani	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	96	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	97	P.S.3	P.S.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	98	1Dana	1Dana	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	99	-	-	:
work_il2ytikkcvhktlpwxw46dgflri	51	100	Farber	Farber	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	101	Cancer	Cancer	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	102	Institute	Institute	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	103	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	104	Boston	Boston	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	105	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	106	MA	MA	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	107	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	51	108	2Massachusetts	2Massachusetts	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	109	General	General	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	110	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	111	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	112	Boston	Boston	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	113	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	114	MA	MA	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	115	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	51	116	3Fate	3Fate	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	117	Therapeutics	Therapeutics	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	118	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	119	San	San	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	120	Diego	Diego	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	121	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	122	CA	CA	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	123	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	51	124	4Beth	4Beth	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	125	Israel	Israel	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	126	Deaconess	Deaconess	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	127	Medical	Medical	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	128	Center	Center	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	129	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	130	Boston	Boston	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	131	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	132	MA	MA	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	133	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	51	134	5Brigham	5Brigham	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	135	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	51	136	Women	Women	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	137	’s	’s	POS
work_il2ytikkcvhktlpwxw46dgflri	51	138	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	139	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	140	Boston	Boston	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	141	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	142	MA	MA	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	143	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	51	144	6Dana	6Dana	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	145	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	51	146	Farber	Farber	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	147	Cancer	Cancer	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	148	Institute	Institute	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	149	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	150	Boston	Boston	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	151	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	152	MA	MA	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	153	Through	through	IN
work_il2ytikkcvhktlpwxw46dgflri	51	154	an	an	DT
work_il2ytikkcvhktlpwxw46dgflri	51	155	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	51	156	vivo	vivo	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	157	zebrafish	zebrafish	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	158	screen	screen	NN
work_il2ytikkcvhktlpwxw46dgflri	51	159	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	51	160	modulators	modulator	NNS
work_il2ytikkcvhktlpwxw46dgflri	51	161	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	51	162	hematopoi-	hematopoi-	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	163	etic	etic	JJ
work_il2ytikkcvhktlpwxw46dgflri	51	164	stem	stem	NN
work_il2ytikkcvhktlpwxw46dgflri	51	165	cell	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	51	166	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	51	167	HSC	HSC	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	168	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	51	169	development	development	NN
work_il2ytikkcvhktlpwxw46dgflri	51	170	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	171	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	51	172	small	small	JJ
work_il2ytikkcvhktlpwxw46dgflri	51	173	molecule	molecule	NN
work_il2ytikkcvhktlpwxw46dgflri	51	174	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	175	16,16-dimethyl	16,16-dimethyl	CD
work_il2ytikkcvhktlpwxw46dgflri	51	176	prostaglandin	prostaglandin	NN
work_il2ytikkcvhktlpwxw46dgflri	51	177	E2	E2	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	178	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	51	179	FT1050	FT1050	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	180	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	51	181	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	51	182	identified	identify	VBN
work_il2ytikkcvhktlpwxw46dgflri	51	183	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	51	184	North	North	NNP
work_il2ytikkcvhktlpwxw46dgflri	51	185	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	51	186	2007	2007	CD
work_il2ytikkcvhktlpwxw46dgflri	51	187	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	51	188	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	52	1	FT1050	FT1050	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	2	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	52	3	shown	show	VBN
work_il2ytikkcvhktlpwxw46dgflri	52	4	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	52	5	enhance	enhance	VB
work_il2ytikkcvhktlpwxw46dgflri	52	6	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	52	7	engraftment	engraftment	JJ
work_il2ytikkcvhktlpwxw46dgflri	52	8	potential	potential	NN
work_il2ytikkcvhktlpwxw46dgflri	52	9	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	52	10	HSCs	HSCs	NNPS
work_il2ytikkcvhktlpwxw46dgflri	52	11	from	from	IN
work_il2ytikkcvhktlpwxw46dgflri	52	12	mu-	mu-	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	13	rine	rine	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	14	bone	bone	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	15	marrow	marrow	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	16	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	52	17	mBM	mBM	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	18	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	52	19	or	or	CC
work_il2ytikkcvhktlpwxw46dgflri	52	20	human	human	JJ
work_il2ytikkcvhktlpwxw46dgflri	52	21	umbilical	umbilical	JJ
work_il2ytikkcvhktlpwxw46dgflri	52	22	cord	cord	NN
work_il2ytikkcvhktlpwxw46dgflri	52	23	blood	blood	NN
work_il2ytikkcvhktlpwxw46dgflri	52	24	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	52	25	hCB	hCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	26	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	52	27	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	52	28	murine	murine	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	29	engraftment	engraftment	NN
work_il2ytikkcvhktlpwxw46dgflri	52	30	models	model	NNS
work_il2ytikkcvhktlpwxw46dgflri	52	31	through	through	IN
work_il2ytikkcvhktlpwxw46dgflri	52	32	an	an	DT
work_il2ytikkcvhktlpwxw46dgflri	52	33	increase	increase	NN
work_il2ytikkcvhktlpwxw46dgflri	52	34	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	52	35	proliferation	proliferation	NN
work_il2ytikkcvhktlpwxw46dgflri	52	36	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	52	37	survival	survival	NN
work_il2ytikkcvhktlpwxw46dgflri	52	38	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	52	39	migration	migration	NN
work_il2ytikkcvhktlpwxw46dgflri	52	40	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	52	41	homing	homing	NN
work_il2ytikkcvhktlpwxw46dgflri	52	42	after	after	IN
work_il2ytikkcvhktlpwxw46dgflri	52	43	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	52	44	brief	brief	NN
work_il2ytikkcvhktlpwxw46dgflri	52	45	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	52	46	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	52	47	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	52	48	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	52	49	hr	hr	NN
work_il2ytikkcvhktlpwxw46dgflri	52	50	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	52	51	ex	ex	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	52	vivo	vivo	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	53	treat-	treat-	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	54	ment	ment	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	55	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	52	56	North	North	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	57	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	52	58	2007	2007	CD
work_il2ytikkcvhktlpwxw46dgflri	52	59	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	52	60	North	North	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	61	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	52	62	2009	2009	CD
work_il2ytikkcvhktlpwxw46dgflri	52	63	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	52	64	Hoggatt	Hoggatt	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	65	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	52	66	2009	2009	CD
work_il2ytikkcvhktlpwxw46dgflri	52	67	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	52	68	North	North	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	69	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	52	70	Goessling	Goessling	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	71	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	52	72	Zon	Zon	NNP
work_il2ytikkcvhktlpwxw46dgflri	52	73	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	52	74	unpublished	unpublished	JJ
work_il2ytikkcvhktlpwxw46dgflri	52	75	data	datum	NNS
work_il2ytikkcvhktlpwxw46dgflri	52	76	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	52	77	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	53	1	We	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	53	2	further	further	RB
work_il2ytikkcvhktlpwxw46dgflri	53	3	optimized	optimize	VBD
work_il2ytikkcvhktlpwxw46dgflri	53	4	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	53	5	ex	ex	NNP
work_il2ytikkcvhktlpwxw46dgflri	53	6	vivo	vivo	NNP
work_il2ytikkcvhktlpwxw46dgflri	53	7	hCB	hCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	53	8	incu-	incu-	NNP
work_il2ytikkcvhktlpwxw46dgflri	53	9	bation	bation	NNP
work_il2ytikkcvhktlpwxw46dgflri	53	10	protocol	protocol	NNP
work_il2ytikkcvhktlpwxw46dgflri	53	11	using	use	VBG
work_il2ytikkcvhktlpwxw46dgflri	53	12	whole	whole	JJ
work_il2ytikkcvhktlpwxw46dgflri	53	13	genome	genome	JJ
work_il2ytikkcvhktlpwxw46dgflri	53	14	expression	expression	NN
work_il2ytikkcvhktlpwxw46dgflri	53	15	arrays	array	NNS
work_il2ytikkcvhktlpwxw46dgflri	53	16	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	53	17	deter-	deter-	NNP
work_il2ytikkcvhktlpwxw46dgflri	53	18	mined	mine	VBD
work_il2ytikkcvhktlpwxw46dgflri	53	19	that	that	IN
work_il2ytikkcvhktlpwxw46dgflri	53	20	HSC	HSC	NNP
work_il2ytikkcvhktlpwxw46dgflri	53	21	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	53	22	containing	contain	VBG
work_il2ytikkcvhktlpwxw46dgflri	53	23	cell	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	53	24	products	product	NNS
work_il2ytikkcvhktlpwxw46dgflri	53	25	should	should	MD
work_il2ytikkcvhktlpwxw46dgflri	53	26	be	be	VB
work_il2ytikkcvhktlpwxw46dgflri	53	27	incubated	incubate	VBN
work_il2ytikkcvhktlpwxw46dgflri	53	28	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	53	29	10mM	10mm	CD
work_il2ytikkcvhktlpwxw46dgflri	53	30	FT1050	FT1050	NNP
work_il2ytikkcvhktlpwxw46dgflri	53	31	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	53	32	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	53	33	hrs	hrs	NN
work_il2ytikkcvhktlpwxw46dgflri	53	34	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	53	35	37	37	CD
work_il2ytikkcvhktlpwxw46dgflri	53	36	�	�	NNS
work_il2ytikkcvhktlpwxw46dgflri	53	37	C	C	NNP
work_il2ytikkcvhktlpwxw46dgflri	53	38	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	53	39	obtain	obtain	VB
work_il2ytikkcvhktlpwxw46dgflri	53	40	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	53	41	optimal	optimal	JJ
work_il2ytikkcvhktlpwxw46dgflri	53	42	response	response	NN
work_il2ytikkcvhktlpwxw46dgflri	53	43	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	54	1	In	in	IN
work_il2ytikkcvhktlpwxw46dgflri	54	2	addition	addition	NN
work_il2ytikkcvhktlpwxw46dgflri	54	3	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	54	4	we	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	54	5	observed	observe	VBD
work_il2ytikkcvhktlpwxw46dgflri	54	6	that	that	IN
work_il2ytikkcvhktlpwxw46dgflri	54	7	FT1050	FT1050	NNP
work_il2ytikkcvhktlpwxw46dgflri	54	8	induces	induce	VBZ
work_il2ytikkcvhktlpwxw46dgflri	54	9	similar	similar	JJ
work_il2ytikkcvhktlpwxw46dgflri	54	10	gene	gene	NN
work_il2ytikkcvhktlpwxw46dgflri	54	11	expres-	expres-	VBZ
work_il2ytikkcvhktlpwxw46dgflri	54	12	sion	sion	NN
work_il2ytikkcvhktlpwxw46dgflri	54	13	changes	change	NNS
work_il2ytikkcvhktlpwxw46dgflri	54	14	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	54	15	hBM-	hBM-	NNP
work_il2ytikkcvhktlpwxw46dgflri	54	16	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	54	17	mobilized	mobilize	VBD
work_il2ytikkcvhktlpwxw46dgflri	54	18	peripheral	peripheral	JJ
work_il2ytikkcvhktlpwxw46dgflri	54	19	blood	blood	NN
work_il2ytikkcvhktlpwxw46dgflri	54	20	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	54	21	derived	derive	VBN
work_il2ytikkcvhktlpwxw46dgflri	54	22	CD341	cd341	NN
work_il2ytikkcvhktlpwxw46dgflri	54	23	cells	cell	NNS
work_il2ytikkcvhktlpwxw46dgflri	54	24	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	55	1	Subsequent	subsequent	JJ
work_il2ytikkcvhktlpwxw46dgflri	55	2	functional	functional	JJ
work_il2ytikkcvhktlpwxw46dgflri	55	3	studies	study	NNS
work_il2ytikkcvhktlpwxw46dgflri	55	4	demonstrated	demonstrate	VBD
work_il2ytikkcvhktlpwxw46dgflri	55	5	that	that	IN
work_il2ytikkcvhktlpwxw46dgflri	55	6	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	55	7	keeping	keep	VBG
work_il2ytikkcvhktlpwxw46dgflri	55	8	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	55	9	increases	increase	NNS
work_il2ytikkcvhktlpwxw46dgflri	55	10	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	55	11	up	up	IN
work_il2ytikkcvhktlpwxw46dgflri	55	12	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	55	13	18-fold	18-fold	CD
work_il2ytikkcvhktlpwxw46dgflri	55	14	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	55	15	CXCR4	cxcr4	JJ
work_il2ytikkcvhktlpwxw46dgflri	55	16	gene	gene	NN
work_il2ytikkcvhktlpwxw46dgflri	55	17	expression	expression	NN
work_il2ytikkcvhktlpwxw46dgflri	55	18	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	55	19	cell	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	55	20	surface	surface	NN
work_il2ytikkcvhktlpwxw46dgflri	55	21	CXCR4	CXCR4	VBG
work_il2ytikkcvhktlpwxw46dgflri	55	22	protein	protein	NN
work_il2ytikkcvhktlpwxw46dgflri	55	23	expression	expression	NN
work_il2ytikkcvhktlpwxw46dgflri	55	24	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	55	25	also	also	RB
work_il2ytikkcvhktlpwxw46dgflri	55	26	significantly	significantly	RB
work_il2ytikkcvhktlpwxw46dgflri	55	27	in-	in-	RB
work_il2ytikkcvhktlpwxw46dgflri	55	28	creased	crease	VBN
work_il2ytikkcvhktlpwxw46dgflri	55	29	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	56	1	One	one	CD
work_il2ytikkcvhktlpwxw46dgflri	56	2	hour	hour	NN
work_il2ytikkcvhktlpwxw46dgflri	56	3	after	after	IN
work_il2ytikkcvhktlpwxw46dgflri	56	4	treatment	treatment	NN
work_il2ytikkcvhktlpwxw46dgflri	56	5	with10mM	with10mm	JJ
work_il2ytikkcvhktlpwxw46dgflri	56	6	FT1050	FT1050	NNP
work_il2ytikkcvhktlpwxw46dgflri	56	7	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	56	8	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	56	9	hrs	hrs	NN
work_il2ytikkcvhktlpwxw46dgflri	56	10	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	56	11	37	37	CD
work_il2ytikkcvhktlpwxw46dgflri	56	12	�	�	NNP
work_il2ytikkcvhktlpwxw46dgflri	56	13	C	C	NNP
work_il2ytikkcvhktlpwxw46dgflri	56	14	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	56	15	4861.9	4861.9	CD
work_il2ytikkcvhktlpwxw46dgflri	56	16	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	56	17	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	56	18	CB	CB	NNP
work_il2ytikkcvhktlpwxw46dgflri	56	19	CD341	CD341	NNP
work_il2ytikkcvhktlpwxw46dgflri	56	20	cells	cell	NNS
work_il2ytikkcvhktlpwxw46dgflri	56	21	expressed	express	VBD
work_il2ytikkcvhktlpwxw46dgflri	56	22	CXCR4	CXCR4	NNS
work_il2ytikkcvhktlpwxw46dgflri	56	23	compared	compare	VBN
work_il2ytikkcvhktlpwxw46dgflri	56	24	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	56	25	3.560.01	3.560.01	CD
work_il2ytikkcvhktlpwxw46dgflri	56	26	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	56	27	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	56	28	DMSO	DMSO	NNP
work_il2ytikkcvhktlpwxw46dgflri	56	29	control	control	NN
work_il2ytikkcvhktlpwxw46dgflri	56	30	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	56	31	p\0.05	p\0.05	NNP
work_il2ytikkcvhktlpwxw46dgflri	56	32	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	56	33	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	57	1	In	in	IN
work_il2ytikkcvhktlpwxw46dgflri	57	2	vivo	vivo	NNP
work_il2ytikkcvhktlpwxw46dgflri	57	3	CFU	CFU	NNP
work_il2ytikkcvhktlpwxw46dgflri	57	4	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	57	5	S12	S12	NNP
work_il2ytikkcvhktlpwxw46dgflri	57	6	anal-	anal-	JJ
work_il2ytikkcvhktlpwxw46dgflri	57	7	ysis	ysis	NN
work_il2ytikkcvhktlpwxw46dgflri	57	8	showed	show	VBD
work_il2ytikkcvhktlpwxw46dgflri	57	9	that	that	IN
work_il2ytikkcvhktlpwxw46dgflri	57	10	treatment	treatment	NN
work_il2ytikkcvhktlpwxw46dgflri	57	11	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	57	12	mBM	mbm	NN
work_il2ytikkcvhktlpwxw46dgflri	57	13	cells	cell	NNS
work_il2ytikkcvhktlpwxw46dgflri	57	14	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	57	15	10mM	10mm	CD
work_il2ytikkcvhktlpwxw46dgflri	57	16	FT1050	FT1050	NNP
work_il2ytikkcvhktlpwxw46dgflri	57	17	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	57	18	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	57	19	hrs	hrs	NN
work_il2ytikkcvhktlpwxw46dgflri	57	20	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	57	21	37	37	CD
work_il2ytikkcvhktlpwxw46dgflri	57	22	�	�	NNP
work_il2ytikkcvhktlpwxw46dgflri	57	23	C	C	NNP
work_il2ytikkcvhktlpwxw46dgflri	57	24	resulted	result	VBD
work_il2ytikkcvhktlpwxw46dgflri	57	25	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	57	26	greater	great	JJR
work_il2ytikkcvhktlpwxw46dgflri	57	27	proliferation	proliferation	NN
work_il2ytikkcvhktlpwxw46dgflri	57	28	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	57	29	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	57	30	statistically	statistically	RB
work_il2ytikkcvhktlpwxw46dgflri	57	31	signif-	signif-	JJ
work_il2ytikkcvhktlpwxw46dgflri	57	32	icant	icant	NN
work_il2ytikkcvhktlpwxw46dgflri	57	33	increase	increase	NN
work_il2ytikkcvhktlpwxw46dgflri	57	34	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	57	35	colony	colony	NN
work_il2ytikkcvhktlpwxw46dgflri	57	36	formation	formation	NN
work_il2ytikkcvhktlpwxw46dgflri	57	37	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	57	38	11.561.4	11.561.4	CD
work_il2ytikkcvhktlpwxw46dgflri	57	39	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	57	40	compared	compare	VBN
work_il2ytikkcvhktlpwxw46dgflri	57	41	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	57	42	460.8	460.8	CD
work_il2ytikkcvhktlpwxw46dgflri	57	43	colonies	colony	NNS
work_il2ytikkcvhktlpwxw46dgflri	57	44	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	57	45	DMSO	DMSO	NNP
work_il2ytikkcvhktlpwxw46dgflri	57	46	control	control	NN
work_il2ytikkcvhktlpwxw46dgflri	57	47	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	57	48	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	57	49	\	\	NNP
work_il2ytikkcvhktlpwxw46dgflri	57	50	0.001	0.001	CD
work_il2ytikkcvhktlpwxw46dgflri	57	51	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	57	52	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	58	1	This	this	DT
work_il2ytikkcvhktlpwxw46dgflri	58	2	short	short	JJ
work_il2ytikkcvhktlpwxw46dgflri	58	3	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	58	4	term	term	NN
work_il2ytikkcvhktlpwxw46dgflri	58	5	ex	ex	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	6	vivo	vivo	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	7	incubation	incubation	NN
work_il2ytikkcvhktlpwxw46dgflri	58	8	protocol	protocol	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	9	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	58	10	10mM	10mm	CD
work_il2ytikkcvhktlpwxw46dgflri	58	11	FT1050	FT1050	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	12	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	58	13	2	2	CD
work_il2ytikkcvhktlpwxw46dgflri	58	14	hrs	hrs	NN
work_il2ytikkcvhktlpwxw46dgflri	58	15	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	58	16	37	37	CD
work_il2ytikkcvhktlpwxw46dgflri	58	17	�	�	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	18	C	C	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	19	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	58	20	has	have	VBZ
work_il2ytikkcvhktlpwxw46dgflri	58	21	been	be	VBN
work_il2ytikkcvhktlpwxw46dgflri	58	22	in-	in-	RB
work_il2ytikkcvhktlpwxw46dgflri	58	23	troduced	troduce	VBN
work_il2ytikkcvhktlpwxw46dgflri	58	24	into	into	IN
work_il2ytikkcvhktlpwxw46dgflri	58	25	an	an	DT
work_il2ytikkcvhktlpwxw46dgflri	58	26	ongoing	ongoing	JJ
work_il2ytikkcvhktlpwxw46dgflri	58	27	Phase	Phase	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	28	Ib	Ib	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	29	clinical	clinical	JJ
work_il2ytikkcvhktlpwxw46dgflri	58	30	trial	trial	NN
work_il2ytikkcvhktlpwxw46dgflri	58	31	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	58	32	adults	adult	NNS
work_il2ytikkcvhktlpwxw46dgflri	58	33	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	58	34	hema-	hema-	JJ
work_il2ytikkcvhktlpwxw46dgflri	58	35	tologic	tologic	JJ
work_il2ytikkcvhktlpwxw46dgflri	58	36	malignancies	malignancy	NNS
work_il2ytikkcvhktlpwxw46dgflri	58	37	receiving	receive	VBG
work_il2ytikkcvhktlpwxw46dgflri	58	38	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	58	39	nonmyeloablative	nonmyeloablative	JJ
work_il2ytikkcvhktlpwxw46dgflri	58	40	conditioning	conditioning	NN
work_il2ytikkcvhktlpwxw46dgflri	58	41	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	58	42	melphalan	melphalan	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	43	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	58	44	fludarabine	fludarabine	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	45	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	58	46	ATG	ATG	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	47	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	58	48	followed	follow	VBN
work_il2ytikkcvhktlpwxw46dgflri	58	49	by	by	IN
work_il2ytikkcvhktlpwxw46dgflri	58	50	double	double	JJ
work_il2ytikkcvhktlpwxw46dgflri	58	51	hCB	hcb	CD
work_il2ytikkcvhktlpwxw46dgflri	58	52	trans-	trans-	JJ
work_il2ytikkcvhktlpwxw46dgflri	58	53	plantation	plantation	NN
work_il2ytikkcvhktlpwxw46dgflri	58	54	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	58	55	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	58	56	which	which	WDT
work_il2ytikkcvhktlpwxw46dgflri	58	57	one	one	CD
work_il2ytikkcvhktlpwxw46dgflri	58	58	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	58	59	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	58	60	two	two	CD
work_il2ytikkcvhktlpwxw46dgflri	58	61	hCBs	hcb	NNS
work_il2ytikkcvhktlpwxw46dgflri	58	62	is	be	VBZ
work_il2ytikkcvhktlpwxw46dgflri	58	63	incubated	incubate	VBN
work_il2ytikkcvhktlpwxw46dgflri	58	64	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	58	65	FT1050	FT1050	NNP
work_il2ytikkcvhktlpwxw46dgflri	58	66	prior	prior	RB
work_il2ytikkcvhktlpwxw46dgflri	58	67	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	58	68	infusion	infusion	NN
work_il2ytikkcvhktlpwxw46dgflri	58	69	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	59	1	The	the	DT
work_il2ytikkcvhktlpwxw46dgflri	59	2	primary	primary	JJ
work_il2ytikkcvhktlpwxw46dgflri	59	3	objective	objective	NN
work_il2ytikkcvhktlpwxw46dgflri	59	4	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	59	5	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	59	6	study	study	NN
work_il2ytikkcvhktlpwxw46dgflri	59	7	is	be	VBZ
work_il2ytikkcvhktlpwxw46dgflri	59	8	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	59	9	determine	determine	VB
work_il2ytikkcvhktlpwxw46dgflri	59	10	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	59	11	safety	safety	NN
work_il2ytikkcvhktlpwxw46dgflri	59	12	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	59	13	FT1050	FT1050	NNP
work_il2ytikkcvhktlpwxw46dgflri	59	14	treatment	treatment	NN
work_il2ytikkcvhktlpwxw46dgflri	59	15	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	59	16	hCB	hCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	59	17	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	60	1	Preliminary	preliminary	JJ
work_il2ytikkcvhktlpwxw46dgflri	60	2	data	datum	NNS
work_il2ytikkcvhktlpwxw46dgflri	60	3	demonstrate	demonstrate	VBP
work_il2ytikkcvhktlpwxw46dgflri	60	4	that	that	IN
work_il2ytikkcvhktlpwxw46dgflri	60	5	this	this	DT
work_il2ytikkcvhktlpwxw46dgflri	60	6	ex	ex	NNP
work_il2ytikkcvhktlpwxw46dgflri	60	7	vivo	vivo	NN
work_il2ytikkcvhktlpwxw46dgflri	60	8	incubation	incubation	NN
work_il2ytikkcvhktlpwxw46dgflri	60	9	can	can	MD
work_il2ytikkcvhktlpwxw46dgflri	60	10	be	be	VB
work_il2ytikkcvhktlpwxw46dgflri	60	11	reliably	reliably	RB
work_il2ytikkcvhktlpwxw46dgflri	60	12	per-	per-	RB
work_il2ytikkcvhktlpwxw46dgflri	60	13	formed	form	VBN
work_il2ytikkcvhktlpwxw46dgflri	60	14	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	60	15	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	60	16	clinical	clinical	JJ
work_il2ytikkcvhktlpwxw46dgflri	60	17	site	site	NN
work_il2ytikkcvhktlpwxw46dgflri	60	18	on	on	IN
work_il2ytikkcvhktlpwxw46dgflri	60	19	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	60	20	day	day	NN
work_il2ytikkcvhktlpwxw46dgflri	60	21	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	60	22	infusion	infusion	NN
work_il2ytikkcvhktlpwxw46dgflri	60	23	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	60	24	good	good	JJ
work_il2ytikkcvhktlpwxw46dgflri	60	25	cell	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	60	26	recov-	recov-	NN
work_il2ytikkcvhktlpwxw46dgflri	60	27	ery	ery	NN
work_il2ytikkcvhktlpwxw46dgflri	60	28	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	60	29	viability	viability	NN
work_il2ytikkcvhktlpwxw46dgflri	60	30	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	61	1	11	11	CD
work_il2ytikkcvhktlpwxw46dgflri	61	2	subjects	subject	NNS
work_il2ytikkcvhktlpwxw46dgflri	61	3	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	61	4	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	61	5	median	median	JJ
work_il2ytikkcvhktlpwxw46dgflri	61	6	age	age	NN
work_il2ytikkcvhktlpwxw46dgflri	61	7	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	61	8	44	44	CD
work_il2ytikkcvhktlpwxw46dgflri	61	9	years	year	NNS
work_il2ytikkcvhktlpwxw46dgflri	61	10	have	have	VBP
work_il2ytikkcvhktlpwxw46dgflri	61	11	been	be	VBN
work_il2ytikkcvhktlpwxw46dgflri	61	12	accrued	accrue	VBN
work_il2ytikkcvhktlpwxw46dgflri	61	13	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	61	14	date	date	NN
work_il2ytikkcvhktlpwxw46dgflri	61	15	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	61	16	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	61	17	which	which	WDT
work_il2ytikkcvhktlpwxw46dgflri	61	18	two	two	CD
work_il2ytikkcvhktlpwxw46dgflri	61	19	have	have	VBP
work_il2ytikkcvhktlpwxw46dgflri	61	20	been	be	VBN
work_il2ytikkcvhktlpwxw46dgflri	61	21	treated	treat	VBN
work_il2ytikkcvhktlpwxw46dgflri	61	22	using	use	VBG
work_il2ytikkcvhktlpwxw46dgflri	61	23	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	61	24	optimized	optimize	VBN
work_il2ytikkcvhktlpwxw46dgflri	61	25	ex	ex	NNP
work_il2ytikkcvhktlpwxw46dgflri	61	26	vivo	vivo	NNP
work_il2ytikkcvhktlpwxw46dgflri	61	27	incubation	incubation	NN
work_il2ytikkcvhktlpwxw46dgflri	61	28	protocol	protocol	NNP
work_il2ytikkcvhktlpwxw46dgflri	61	29	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	62	1	10	10	CD
work_il2ytikkcvhktlpwxw46dgflri	62	2	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	62	3	11	11	CD
work_il2ytikkcvhktlpwxw46dgflri	62	4	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	62	5	have	have	VBP
work_il2ytikkcvhktlpwxw46dgflri	62	6	achieved	achieve	VBN
work_il2ytikkcvhktlpwxw46dgflri	62	7	an	an	DT
work_il2ytikkcvhktlpwxw46dgflri	62	8	ANC	ANC	NNP
work_il2ytikkcvhktlpwxw46dgflri	62	9	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	63	1	500	500	CD
work_il2ytikkcvhktlpwxw46dgflri	63	2	before	before	IN
work_il2ytikkcvhktlpwxw46dgflri	63	3	Day	day	NN
work_il2ytikkcvhktlpwxw46dgflri	63	4	42	42	CD
work_il2ytikkcvhktlpwxw46dgflri	63	5	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	64	1	Transplant	transplant	NN
work_il2ytikkcvhktlpwxw46dgflri	64	2	related	related	JJ
work_il2ytikkcvhktlpwxw46dgflri	64	3	mortality	mortality	NN
work_il2ytikkcvhktlpwxw46dgflri	64	4	has	have	VBZ
work_il2ytikkcvhktlpwxw46dgflri	64	5	been	be	VBN
work_il2ytikkcvhktlpwxw46dgflri	64	6	low	low	JJ
work_il2ytikkcvhktlpwxw46dgflri	64	7	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	64	8	one	one	CD
work_il2ytikkcvhktlpwxw46dgflri	64	9	death	death	NN
work_il2ytikkcvhktlpwxw46dgflri	64	10	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	64	11	Day	day	NN
work_il2ytikkcvhktlpwxw46dgflri	64	12	53	53	CD
work_il2ytikkcvhktlpwxw46dgflri	64	13	from	from	IN
work_il2ytikkcvhktlpwxw46dgflri	64	14	respiratory	respiratory	JJ
work_il2ytikkcvhktlpwxw46dgflri	64	15	failure	failure	NN
work_il2ytikkcvhktlpwxw46dgflri	64	16	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	65	1	9	9	CD
work_il2ytikkcvhktlpwxw46dgflri	65	2	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	65	3	are	be	VBP
work_il2ytikkcvhktlpwxw46dgflri	65	4	alive	alive	JJ
work_il2ytikkcvhktlpwxw46dgflri	65	5	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	65	6	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	65	7	which	which	WDT
work_il2ytikkcvhktlpwxw46dgflri	65	8	7	7	CD
work_il2ytikkcvhktlpwxw46dgflri	65	9	are	be	VBP
work_il2ytikkcvhktlpwxw46dgflri	65	10	disease	disease	NN
work_il2ytikkcvhktlpwxw46dgflri	65	11	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	65	12	free	free	JJ
work_il2ytikkcvhktlpwxw46dgflri	65	13	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	66	1	Accrual	Accrual	NNP
work_il2ytikkcvhktlpwxw46dgflri	66	2	is	be	VBZ
work_il2ytikkcvhktlpwxw46dgflri	66	3	ongoing	ongoing	JJ
work_il2ytikkcvhktlpwxw46dgflri	66	4	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	67	1	199	199	CD
work_il2ytikkcvhktlpwxw46dgflri	67	2	ALLOGENEIC	ALLOGENEIC	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	3	TRANSPLANTATION	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	67	4	USING	use	VBG
work_il2ytikkcvhktlpwxw46dgflri	67	5	HAPLOIDENTICAL	haploidentical	NN
work_il2ytikkcvhktlpwxw46dgflri	67	6	DONOR	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	67	7	VER-	ver-	NN
work_il2ytikkcvhktlpwxw46dgflri	67	8	SUS	SUS	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	9	UNRELATED	UNRELATED	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	10	CORD	cord	NN
work_il2ytikkcvhktlpwxw46dgflri	67	11	BLOOD	blood	NN
work_il2ytikkcvhktlpwxw46dgflri	67	12	DONOR	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	67	13	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	67	14	A	a	DT
work_il2ytikkcvhktlpwxw46dgflri	67	15	SINGLE	SINGLE	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	16	CENTER	center	NN
work_il2ytikkcvhktlpwxw46dgflri	67	17	RETROSPEC-	RETROSPEC-	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	18	TIVE	TIVE	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	19	STUDY	STUDY	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	20	Gonzalez	Gonzalez	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	21	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	67	22	Vicent	Vicent	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	23	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	24	M.	M.	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	25	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	26	Molina	Molina	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	27	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	28	B.	B.	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	29	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	30	Andion	Andion	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	31	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	32	M.	M.	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	33	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	34	Sevilla	Sevilla	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	35	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	36	J.	J.	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	37	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	38	Ramirez	Ramirez	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	39	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	40	M.	M.	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	41	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	42	Perez	Perez	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	43	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	44	A.	A.	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	45	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	46	Lassaletta	Lassaletta	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	47	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	48	A.	A.	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	49	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	50	Diaz	Diaz	NNP
work_il2ytikkcvhktlpwxw46dgflri	67	51	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	67	52	M.A.	M.A.	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	1	Ni	ni	RB
work_il2ytikkcvhktlpwxw46dgflri	68	2	~	~	NFP
work_il2ytikkcvhktlpwxw46dgflri	68	3	no	no	DT
work_il2ytikkcvhktlpwxw46dgflri	68	4	Jesus	Jesus	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	5	Childre	Childre	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	6	�	�	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	7	ns	ns	IN
work_il2ytikkcvhktlpwxw46dgflri	68	8	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	9	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	68	10	Madrid	Madrid	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	11	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	68	12	Spain	Spain	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	13	We	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	68	14	have	have	VBP
work_il2ytikkcvhktlpwxw46dgflri	68	15	performed	perform	VBN
work_il2ytikkcvhktlpwxw46dgflri	68	16	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	68	17	retrospective	retrospective	JJ
work_il2ytikkcvhktlpwxw46dgflri	68	18	comparison	comparison	NN
work_il2ytikkcvhktlpwxw46dgflri	68	19	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	68	20	pediatric	pediatric	JJ
work_il2ytikkcvhktlpwxw46dgflri	68	21	pa-	pa-	NN
work_il2ytikkcvhktlpwxw46dgflri	68	22	tients	tient	NNS
work_il2ytikkcvhktlpwxw46dgflri	68	23	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	68	24	leukemia	leukemia	NN
work_il2ytikkcvhktlpwxw46dgflri	68	25	receiving	receive	VBG
work_il2ytikkcvhktlpwxw46dgflri	68	26	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	68	27	haplo	haplo	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	28	transplant	transplant	NN
work_il2ytikkcvhktlpwxw46dgflri	68	29	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	68	30	n	n	CC
work_il2ytikkcvhktlpwxw46dgflri	68	31	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	68	32	29	29	CD
work_il2ytikkcvhktlpwxw46dgflri	68	33	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	68	34	or	or	CC
work_il2ytikkcvhktlpwxw46dgflri	68	35	UCBT	UCBT	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	36	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	68	37	n	n	CC
work_il2ytikkcvhktlpwxw46dgflri	68	38	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	68	39	38	38	CD
work_il2ytikkcvhktlpwxw46dgflri	68	40	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	68	41	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	68	42	Ni	Ni	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	43	~	~	NFP
work_il2ytikkcvhktlpwxw46dgflri	68	44	no	no	DT
work_il2ytikkcvhktlpwxw46dgflri	68	45	Jesus	Jesus	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	46	Children	Children	NNPS
work_il2ytikkcvhktlpwxw46dgflri	68	47	’s	’s	POS
work_il2ytikkcvhktlpwxw46dgflri	68	48	Hospital	Hospital	NNP
work_il2ytikkcvhktlpwxw46dgflri	68	49	since	since	IN
work_il2ytikkcvhktlpwxw46dgflri	68	50	1996	1996	CD
work_il2ytikkcvhktlpwxw46dgflri	68	51	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	68	52	2010	2010	CD
work_il2ytikkcvhktlpwxw46dgflri	68	53	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	69	1	There	there	EX
work_il2ytikkcvhktlpwxw46dgflri	69	2	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	69	3	not	not	RB
work_il2ytikkcvhktlpwxw46dgflri	69	4	significant	significant	JJ
work_il2ytikkcvhktlpwxw46dgflri	69	5	differences	difference	NNS
work_il2ytikkcvhktlpwxw46dgflri	69	6	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	69	7	immunophenotype	immunophenotype	NN
work_il2ytikkcvhktlpwxw46dgflri	69	8	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	69	9	disease	disease	NN
work_il2ytikkcvhktlpwxw46dgflri	69	10	status	status	NN
work_il2ytikkcvhktlpwxw46dgflri	69	11	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	69	12	antecedent	antecedent	NN
work_il2ytikkcvhktlpwxw46dgflri	69	13	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	69	14	prior	prior	JJ
work_il2ytikkcvhktlpwxw46dgflri	69	15	autograft	autograft	NN
work_il2ytikkcvhktlpwxw46dgflri	69	16	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	70	1	However	however	RB
work_il2ytikkcvhktlpwxw46dgflri	70	2	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	70	3	haplo	haplo	NNP
work_il2ytikkcvhktlpwxw46dgflri	70	4	re-	re-	NNP
work_il2ytikkcvhktlpwxw46dgflri	70	5	cipients	cipient	NNS
work_il2ytikkcvhktlpwxw46dgflri	70	6	tended	tend	VBD
work_il2ytikkcvhktlpwxw46dgflri	70	7	to	to	TO
work_il2ytikkcvhktlpwxw46dgflri	70	8	be	be	VB
work_il2ytikkcvhktlpwxw46dgflri	70	9	older	old	JJR
work_il2ytikkcvhktlpwxw46dgflri	70	10	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	70	11	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	70	12	male	male	JJ
work_il2ytikkcvhktlpwxw46dgflri	70	13	gender	gender	NN
work_il2ytikkcvhktlpwxw46dgflri	70	14	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	71	1	Engraftment	engraftment	JJ
work_il2ytikkcvhktlpwxw46dgflri	71	2	failure	failure	NN
work_il2ytikkcvhktlpwxw46dgflri	71	3	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	71	4	significantly	significantly	RB
work_il2ytikkcvhktlpwxw46dgflri	71	5	higher	high	JJR
work_il2ytikkcvhktlpwxw46dgflri	71	6	following	follow	VBG
work_il2ytikkcvhktlpwxw46dgflri	71	7	UCBT	UCBT	NNP
work_il2ytikkcvhktlpwxw46dgflri	71	8	965	965	CD
work_il2ytikkcvhktlpwxw46dgflri	71	9	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	71	10	compared	compare	VBN
work_il2ytikkcvhktlpwxw46dgflri	71	11	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	71	12	765	765	CD
work_il2ytikkcvhktlpwxw46dgflri	71	13	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	71	14	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	71	15	haplo	haplo	NNP
work_il2ytikkcvhktlpwxw46dgflri	71	16	transplants	transplant	NNS
work_il2ytikkcvhktlpwxw46dgflri	71	17	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	71	18	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	71	19	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	71	20	0.001	0.001	CD
work_il2ytikkcvhktlpwxw46dgflri	71	21	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	71	22	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	72	1	Median	median	JJ
work_il2ytikkcvhktlpwxw46dgflri	72	2	neutrophil	neutrophil	NNP
work_il2ytikkcvhktlpwxw46dgflri	72	3	engraftment	engraftment	NN
work_il2ytikkcvhktlpwxw46dgflri	72	4	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	72	5	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	72	6	13	13	CD
work_il2ytikkcvhktlpwxw46dgflri	72	7	days	day	NNS
work_il2ytikkcvhktlpwxw46dgflri	72	8	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	72	9	haplo	haplo	NNP
work_il2ytikkcvhktlpwxw46dgflri	72	10	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	72	11	20	20	CD
work_il2ytikkcvhktlpwxw46dgflri	72	12	days	day	NNS
work_il2ytikkcvhktlpwxw46dgflri	72	13	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	72	14	UCBT	UCBT	NNP
work_il2ytikkcvhktlpwxw46dgflri	72	15	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	72	16	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	72	17	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	72	18	0.01	0.01	CD
work_il2ytikkcvhktlpwxw46dgflri	72	19	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	72	20	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	72	21	platelet	platelet	NN
work_il2ytikkcvhktlpwxw46dgflri	72	22	engraftment	engraftment	NN
work_il2ytikkcvhktlpwxw46dgflri	72	23	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	72	24	11	11	CD
work_il2ytikkcvhktlpwxw46dgflri	72	25	days	day	NNS
work_il2ytikkcvhktlpwxw46dgflri	72	26	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	72	27	haplo	haplo	NNP
work_il2ytikkcvhktlpwxw46dgflri	72	28	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	72	29	56	56	CD
work_il2ytikkcvhktlpwxw46dgflri	72	30	days	day	NNS
work_il2ytikkcvhktlpwxw46dgflri	72	31	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	72	32	UCBT	UCBT	NNP
work_il2ytikkcvhktlpwxw46dgflri	72	33	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	72	34	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	72	35	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	72	36	0.0001	0.0001	CD
work_il2ytikkcvhktlpwxw46dgflri	72	37	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	72	38	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	73	1	Supportive	supportive	JJ
work_il2ytikkcvhktlpwxw46dgflri	73	2	care	care	NN
work_il2ytikkcvhktlpwxw46dgflri	73	3	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	73	4	transfusions	transfusion	NNS
work_il2ytikkcvhktlpwxw46dgflri	73	5	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	73	6	antibiotics	antibiotic	NNS
work_il2ytikkcvhktlpwxw46dgflri	73	7	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	73	8	parenteral	parenteral	JJ
work_il2ytikkcvhktlpwxw46dgflri	73	9	nutrition	nutrition	NN
work_il2ytikkcvhktlpwxw46dgflri	73	10	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	73	11	hospitalization	hospitalization	NN
work_il2ytikkcvhktlpwxw46dgflri	73	12	days	day	NNS
work_il2ytikkcvhktlpwxw46dgflri	73	13	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	73	14	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	73	15	sig-	sig-	RB
work_il2ytikkcvhktlpwxw46dgflri	73	16	nificantly	nificantly	RB
work_il2ytikkcvhktlpwxw46dgflri	73	17	higher	high	JJR
work_il2ytikkcvhktlpwxw46dgflri	73	18	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	73	19	cord	cord	NN
work_il2ytikkcvhktlpwxw46dgflri	73	20	blood	blood	NN
work_il2ytikkcvhktlpwxw46dgflri	73	21	transplants	transplant	NNS
work_il2ytikkcvhktlpwxw46dgflri	73	22	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	74	1	TRM	TRM	NNP
work_il2ytikkcvhktlpwxw46dgflri	74	2	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	74	3	acute	acute	JJ
work_il2ytikkcvhktlpwxw46dgflri	74	4	GVHD	GVHD	NNP
work_il2ytikkcvhktlpwxw46dgflri	74	5	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	74	6	more	more	JJR
work_il2ytikkcvhktlpwxw46dgflri	74	7	than	than	IN
work_il2ytikkcvhktlpwxw46dgflri	74	8	grade	grade	NNP
work_il2ytikkcvhktlpwxw46dgflri	74	9	II	II	NNP
work_il2ytikkcvhktlpwxw46dgflri	74	10	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	74	11	incidence	incidence	NN
work_il2ytikkcvhktlpwxw46dgflri	74	12	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	74	13	higher	high	JJR
work_il2ytikkcvhktlpwxw46dgflri	74	14	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	74	15	UCBT	UCBT	NNP
work_il2ytikkcvhktlpwxw46dgflri	74	16	compared	compare	VBN
work_il2ytikkcvhktlpwxw46dgflri	74	17	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	74	18	haplo	haplo	NNP
work_il2ytikkcvhktlpwxw46dgflri	74	19	transplants	transplant	NNS
work_il2ytikkcvhktlpwxw46dgflri	74	20	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	75	1	There	there	EX
work_il2ytikkcvhktlpwxw46dgflri	75	2	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	75	3	not	not	RB
work_il2ytikkcvhktlpwxw46dgflri	75	4	significant	significant	JJ
work_il2ytikkcvhktlpwxw46dgflri	75	5	differences	difference	NNS
work_il2ytikkcvhktlpwxw46dgflri	75	6	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	75	7	chronic	chronic	JJ
work_il2ytikkcvhktlpwxw46dgflri	75	8	GVHD	gvhd	NN
work_il2ytikkcvhktlpwxw46dgflri	75	9	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	75	10	relapse	relapse	VBP
work_il2ytikkcvhktlpwxw46dgflri	75	11	probability	probability	NN
work_il2ytikkcvhktlpwxw46dgflri	75	12	between	between	IN
work_il2ytikkcvhktlpwxw46dgflri	75	13	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	75	14	two	two	CD
work_il2ytikkcvhktlpwxw46dgflri	75	15	groups	group	NNS
work_il2ytikkcvhktlpwxw46dgflri	75	16	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	76	1	Results	result	NNS
work_il2ytikkcvhktlpwxw46dgflri	76	2	are	be	VBP
work_il2ytikkcvhktlpwxw46dgflri	76	3	summarized	summarize	VBN
work_il2ytikkcvhktlpwxw46dgflri	76	4	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	76	5	table	table	NN
work_il2ytikkcvhktlpwxw46dgflri	76	6	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	76	7	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	77	1	Disease	disease	NN
work_il2ytikkcvhktlpwxw46dgflri	77	2	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	77	3	free	free	JJ
work_il2ytikkcvhktlpwxw46dgflri	77	4	survival	survival	NN
work_il2ytikkcvhktlpwxw46dgflri	77	5	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	77	6	DFS	DFS	NNP
work_il2ytikkcvhktlpwxw46dgflri	77	7	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	77	8	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	77	9	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	77	10	median	median	JJ
work_il2ytikkcvhktlpwxw46dgflri	77	11	follow	follow	NN
work_il2ytikkcvhktlpwxw46dgflri	77	12	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	77	13	up	up	NN
work_il2ytikkcvhktlpwxw46dgflri	77	14	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	77	15	16	16	CD
work_il2ytikkcvhktlpwxw46dgflri	77	16	months	month	NNS
work_il2ytikkcvhktlpwxw46dgflri	77	17	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	77	18	range	range	NN
work_il2ytikkcvhktlpwxw46dgflri	77	19	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	77	20	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	77	21	-	-	SYM
work_il2ytikkcvhktlpwxw46dgflri	77	22	42	42	CD
work_il2ytikkcvhktlpwxw46dgflri	77	23	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	77	24	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	77	25	57	57	CD
work_il2ytikkcvhktlpwxw46dgflri	77	26	months	month	NNS
work_il2ytikkcvhktlpwxw46dgflri	77	27	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	77	28	range	range	NN
work_il2ytikkcvhktlpwxw46dgflri	77	29	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	77	30	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	77	31	-	-	SYM
work_il2ytikkcvhktlpwxw46dgflri	77	32	150	150	CD
work_il2ytikkcvhktlpwxw46dgflri	77	33	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	77	34	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	77	35	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	77	36	44610	44610	CD
work_il2ytikkcvhktlpwxw46dgflri	77	37	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	77	38	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	77	39	3267	3267	CD
work_il2ytikkcvhktlpwxw46dgflri	77	40	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	77	41	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	77	42	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	77	43	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	77	44	0.03	0.03	CD
work_il2ytikkcvhktlpwxw46dgflri	77	45	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	77	46	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	77	47	haplo	haplo	NN
work_il2ytikkcvhktlpwxw46dgflri	77	48	transplants	transplant	NNS
work_il2ytikkcvhktlpwxw46dgflri	77	49	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	77	50	UCBT	UCBT	NNP
work_il2ytikkcvhktlpwxw46dgflri	77	51	respectively	respectively	RB
work_il2ytikkcvhktlpwxw46dgflri	77	52	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	78	1	When	when	WRB
work_il2ytikkcvhktlpwxw46dgflri	78	2	we	-PRON-	PRP
work_il2ytikkcvhktlpwxw46dgflri	78	3	analyzed	analyze	VBD
work_il2ytikkcvhktlpwxw46dgflri	78	4	AML	AML	NNP
work_il2ytikkcvhktlpwxw46dgflri	78	5	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	78	6	there	there	EX
work_il2ytikkcvhktlpwxw46dgflri	78	7	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	78	8	not	not	RB
work_il2ytikkcvhktlpwxw46dgflri	78	9	differences	difference	NNS
work_il2ytikkcvhktlpwxw46dgflri	78	10	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	78	11	DFS	DFS	NNP
work_il2ytikkcvhktlpwxw46dgflri	78	12	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	78	13	both	both	DT
work_il2ytikkcvhktlpwxw46dgflri	78	14	type	type	NN
work_il2ytikkcvhktlpwxw46dgflri	78	15	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	78	16	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	78	17	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	78	18	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	78	19	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	78	20	0.6	0.6	CD
work_il2ytikkcvhktlpwxw46dgflri	78	21	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	78	22	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	79	1	However	however	RB
work_il2ytikkcvhktlpwxw46dgflri	79	2	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	79	3	DFS	DFS	NNP
work_il2ytikkcvhktlpwxw46dgflri	79	4	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	79	5	ALL	all	DT
work_il2ytikkcvhktlpwxw46dgflri	79	6	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	79	7	better	well	JJR
work_il2ytikkcvhktlpwxw46dgflri	79	8	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	79	9	haplo	haplo	NNP
work_il2ytikkcvhktlpwxw46dgflri	79	10	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	79	11	41613	41613	CD
work_il2ytikkcvhktlpwxw46dgflri	79	12	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	79	13	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	79	14	against	against	IN
work_il2ytikkcvhktlpwxw46dgflri	79	15	cord	cord	NN
work_il2ytikkcvhktlpwxw46dgflri	79	16	blood	blood	NN
work_il2ytikkcvhktlpwxw46dgflri	79	17	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	79	18	266	266	CD
work_il2ytikkcvhktlpwxw46dgflri	79	19	9	9	CD
work_il2ytikkcvhktlpwxw46dgflri	79	20	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	79	21	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	79	22	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	79	23	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	79	24	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	79	25	0.03	0.03	CD
work_il2ytikkcvhktlpwxw46dgflri	79	26	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	79	27	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	80	1	Ac-	ac-	JJ
work_il2ytikkcvhktlpwxw46dgflri	80	2	cording	cord	VBG
work_il2ytikkcvhktlpwxw46dgflri	80	3	to	to	IN
work_il2ytikkcvhktlpwxw46dgflri	80	4	phase	phase	NN
work_il2ytikkcvhktlpwxw46dgflri	80	5	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	80	6	disease	disease	NN
work_il2ytikkcvhktlpwxw46dgflri	80	7	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	80	8	DFS	DFS	NNP
work_il2ytikkcvhktlpwxw46dgflri	80	9	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	80	10	similar	similar	JJ
work_il2ytikkcvhktlpwxw46dgflri	80	11	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	80	12	early	early	JJ
work_il2ytikkcvhktlpwxw46dgflri	80	13	phase	phase	NN
work_il2ytikkcvhktlpwxw46dgflri	80	14	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	80	15	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	80	16	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	80	17	0.7	0.7	CD
work_il2ytikkcvhktlpwxw46dgflri	80	18	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	80	19	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	80	20	but	but	CC
work_il2ytikkcvhktlpwxw46dgflri	80	21	in	in	IN
work_il2ytikkcvhktlpwxw46dgflri	80	22	advanced	advanced	JJ
work_il2ytikkcvhktlpwxw46dgflri	80	23	phase	phase	NN
work_il2ytikkcvhktlpwxw46dgflri	80	24	outcome	outcome	NN
work_il2ytikkcvhktlpwxw46dgflri	80	25	was	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	80	26	better	well	JJR
work_il2ytikkcvhktlpwxw46dgflri	80	27	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	80	28	haplo	haplo	NNP
work_il2ytikkcvhktlpwxw46dgflri	80	29	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	80	30	37614	37614	CD
work_il2ytikkcvhktlpwxw46dgflri	80	31	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	80	32	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	80	33	ver-	ver-	NNP
work_il2ytikkcvhktlpwxw46dgflri	80	34	sus	sus	NNP
work_il2ytikkcvhktlpwxw46dgflri	80	35	cord	cord	NNP
work_il2ytikkcvhktlpwxw46dgflri	80	36	blood	blood	NN
work_il2ytikkcvhktlpwxw46dgflri	80	37	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	80	38	2168	2168	CD
work_il2ytikkcvhktlpwxw46dgflri	80	39	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	80	40	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	80	41	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	80	42	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	80	43	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	80	44	0.05	0.05	CD
work_il2ytikkcvhktlpwxw46dgflri	80	45	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	80	46	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	81	1	Multivariate	multivariate	JJ
work_il2ytikkcvhktlpwxw46dgflri	81	2	analysis	analysis	NN
work_il2ytikkcvhktlpwxw46dgflri	81	3	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	81	4	DFS	DFS	NNP
work_il2ytikkcvhktlpwxw46dgflri	81	5	showed	show	VBD
work_il2ytikkcvhktlpwxw46dgflri	81	6	that	that	IN
work_il2ytikkcvhktlpwxw46dgflri	81	7	the	the	DT
work_il2ytikkcvhktlpwxw46dgflri	81	8	main	main	JJ
work_il2ytikkcvhktlpwxw46dgflri	81	9	prognostic	prognostic	NN
work_il2ytikkcvhktlpwxw46dgflri	81	10	fac-	fac-	NN
work_il2ytikkcvhktlpwxw46dgflri	81	11	tors	tor	NNS
work_il2ytikkcvhktlpwxw46dgflri	81	12	were	be	VBD
work_il2ytikkcvhktlpwxw46dgflri	81	13	disease	disease	NN
work_il2ytikkcvhktlpwxw46dgflri	81	14	status	status	NN
work_il2ytikkcvhktlpwxw46dgflri	81	15	at	at	IN
work_il2ytikkcvhktlpwxw46dgflri	81	16	transplant	transplant	NN
work_il2ytikkcvhktlpwxw46dgflri	81	17	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	81	18	HR	HR	NNP
work_il2ytikkcvhktlpwxw46dgflri	81	19	2.49	2.49	CD
work_il2ytikkcvhktlpwxw46dgflri	81	20	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	81	21	p	p	NNP
work_il2ytikkcvhktlpwxw46dgflri	81	22	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	81	23	0.02	0.02	CD
work_il2ytikkcvhktlpwxw46dgflri	81	24	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	81	25	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	81	26	chronic	chronic	JJ
work_il2ytikkcvhktlpwxw46dgflri	81	27	GVHD	GVHD	NNP
work_il2ytikkcvhktlpwxw46dgflri	81	28	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	81	29	HR	hr	NN
work_il2ytikkcvhktlpwxw46dgflri	81	30	0.21	0.21	CD
work_il2ytikkcvhktlpwxw46dgflri	81	31	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	81	32	p	p	NNP
work_il2ytikkcvhktlpwxw46dgflri	81	33	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	81	34	0.0001	0.0001	CD
work_il2ytikkcvhktlpwxw46dgflri	81	35	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	81	36	and	and	CC
work_il2ytikkcvhktlpwxw46dgflri	81	37	source	source	NN
work_il2ytikkcvhktlpwxw46dgflri	81	38	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	81	39	stem	stem	NN
work_il2ytikkcvhktlpwxw46dgflri	81	40	cells	cell	NNS
work_il2ytikkcvhktlpwxw46dgflri	81	41	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	81	42	HR	HR	NNP
work_il2ytikkcvhktlpwxw46dgflri	81	43	5.75	5.75	CD
work_il2ytikkcvhktlpwxw46dgflri	81	44	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	81	45	p	p	NN
work_il2ytikkcvhktlpwxw46dgflri	81	46	5	5	CD
work_il2ytikkcvhktlpwxw46dgflri	81	47	0.001	0.001	CD
work_il2ytikkcvhktlpwxw46dgflri	81	48	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	81	49	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	82	1	In	in	IN
work_il2ytikkcvhktlpwxw46dgflri	82	2	conclusion	conclusion	NN
work_il2ytikkcvhktlpwxw46dgflri	82	3	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	82	4	our	-PRON-	PRP$
work_il2ytikkcvhktlpwxw46dgflri	82	5	data	datum	NNS
work_il2ytikkcvhktlpwxw46dgflri	82	6	suggest	suggest	VBP
work_il2ytikkcvhktlpwxw46dgflri	82	7	that	that	IN
work_il2ytikkcvhktlpwxw46dgflri	82	8	haploidentical	haploidentical	JJ
work_il2ytikkcvhktlpwxw46dgflri	82	9	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	82	10	is	be	VBZ
work_il2ytikkcvhktlpwxw46dgflri	82	11	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	82	12	good	good	JJ
work_il2ytikkcvhktlpwxw46dgflri	82	13	alternative	alternative	NN
work_il2ytikkcvhktlpwxw46dgflri	82	14	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	82	15	patients	patient	NNS
work_il2ytikkcvhktlpwxw46dgflri	82	16	lacking	lack	VBG
work_il2ytikkcvhktlpwxw46dgflri	82	17	an	an	DT
work_il2ytikkcvhktlpwxw46dgflri	82	18	HLA	HLA	NNP
work_il2ytikkcvhktlpwxw46dgflri	82	19	identical	identical	JJ
work_il2ytikkcvhktlpwxw46dgflri	82	20	donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	82	21	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	83	1	Table	table	NN
work_il2ytikkcvhktlpwxw46dgflri	83	2	1	1	CD
work_il2ytikkcvhktlpwxw46dgflri	83	3	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	84	1	Results	result	NNS
work_il2ytikkcvhktlpwxw46dgflri	84	2	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	85	1	aGVHD	aGVHD	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	2	>	>	XX
work_il2ytikkcvhktlpwxw46dgflri	85	3	II	II	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	4	TRM	TRM	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	5	Relapse	Relapse	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	6	DFS	DFS	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	7	Haplo	Haplo	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	8	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	85	9	n529	n529	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	10	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	85	11	19±7	19±7	CD
work_il2ytikkcvhktlpwxw46dgflri	85	12	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	85	13	25±9	25±9	CD
work_il2ytikkcvhktlpwxw46dgflri	85	14	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	85	15	48±12	48±12	CD
work_il2ytikkcvhktlpwxw46dgflri	85	16	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	85	17	44±10	44±10	CD
work_il2ytikkcvhktlpwxw46dgflri	85	18	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	85	19	UCB	UCB	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	20	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	85	21	n538	n538	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	22	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	85	23	44±10	44±10	CD
work_il2ytikkcvhktlpwxw46dgflri	85	24	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	85	25	57±9	57±9	CD
work_il2ytikkcvhktlpwxw46dgflri	85	26	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	85	27	25±9	25±9	CD
work_il2ytikkcvhktlpwxw46dgflri	85	28	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	85	29	32±7	32±7	CD
work_il2ytikkcvhktlpwxw46dgflri	85	30	%	%	NN
work_il2ytikkcvhktlpwxw46dgflri	85	31	P	p	NN
work_il2ytikkcvhktlpwxw46dgflri	85	32	0.03	0.03	CD
work_il2ytikkcvhktlpwxw46dgflri	85	33	0.05	0.05	CD
work_il2ytikkcvhktlpwxw46dgflri	85	34	0.7	0.7	CD
work_il2ytikkcvhktlpwxw46dgflri	85	35	0.03	0.03	CD
work_il2ytikkcvhktlpwxw46dgflri	85	36	200	200	CD
work_il2ytikkcvhktlpwxw46dgflri	85	37	CD341	cd341	NN
work_il2ytikkcvhktlpwxw46dgflri	85	38	STEM	stem	JJ
work_il2ytikkcvhktlpwxw46dgflri	85	39	CELL	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	85	40	SELECTION	selection	NN
work_il2ytikkcvhktlpwxw46dgflri	85	41	AND	and	CC
work_il2ytikkcvhktlpwxw46dgflri	85	42	CD31	cd31	NN
work_il2ytikkcvhktlpwxw46dgflri	85	43	ADDBACK	ADDBACK	NNS
work_il2ytikkcvhktlpwxw46dgflri	85	44	FOR	for	IN
work_il2ytikkcvhktlpwxw46dgflri	85	45	PEDIATRIC	pediatric	JJ
work_il2ytikkcvhktlpwxw46dgflri	85	46	RECIPIENTS	recipient	NNS
work_il2ytikkcvhktlpwxw46dgflri	85	47	OF	of	IN
work_il2ytikkcvhktlpwxw46dgflri	85	48	MATCHED	matched	JJ
work_il2ytikkcvhktlpwxw46dgflri	85	49	UNRELATED	unrelated	JJ
work_il2ytikkcvhktlpwxw46dgflri	85	50	ADULT	adult	NN
work_il2ytikkcvhktlpwxw46dgflri	85	51	DONOR	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	85	52	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	85	53	MUD	MUD	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	54	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	85	55	PERIPH-	PERIPH-	VBD
work_il2ytikkcvhktlpwxw46dgflri	85	56	ERAL	ERAL	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	57	BLOOD	blood	NN
work_il2ytikkcvhktlpwxw46dgflri	85	58	STEM	stem	JJ
work_il2ytikkcvhktlpwxw46dgflri	85	59	CELL	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	85	60	TRANSPLANTATION	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	85	61	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	85	62	PBSCT	PBSCT	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	63	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	85	64	PRELIMINARY	PRELIMINARY	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	65	RE-	RE-	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	66	SULTS	SULTS	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	67	OF	of	IN
work_il2ytikkcvhktlpwxw46dgflri	85	68	DAY	DAY	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	69	100	100	CD
work_il2ytikkcvhktlpwxw46dgflri	85	70	TRM	TRM	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	71	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	72	IMMUNE	IMMUNE	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	73	RECONSTITUTION	RECONSTITUTION	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	74	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	85	75	IR	IR	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	76	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	85	77	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	78	PTLD	PTLD	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	79	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	80	SYSTEMIC	systemic	NN
work_il2ytikkcvhktlpwxw46dgflri	85	81	VIRAL	viral	NN
work_il2ytikkcvhktlpwxw46dgflri	85	82	INFECTIONS	infection	NNS
work_il2ytikkcvhktlpwxw46dgflri	85	83	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	85	84	SVI	SVI	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	85	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	85	86	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	87	AND	and	CC
work_il2ytikkcvhktlpwxw46dgflri	85	88	INVASIVE	invasive	JJ
work_il2ytikkcvhktlpwxw46dgflri	85	89	FUNGAL	fungal	NN
work_il2ytikkcvhktlpwxw46dgflri	85	90	INFECTIONS	infection	NNS
work_il2ytikkcvhktlpwxw46dgflri	85	91	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	85	92	IFI	IFI	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	93	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	85	94	Ricci	Ricci	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	95	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	96	A.M.1	A.M.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	97	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	98	Geyer	Geyer	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	99	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	100	M.B.1	M.B.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	101	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	102	Jacobson	Jacobson	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	103	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	104	J.S.2	J.S.2	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	105	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	106	Majzner	Majzner	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	107	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	108	R.1	R.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	109	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	110	Satwani	Satwani	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	111	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	112	P.1	P.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	113	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	114	Bhatia	Bhatia	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	115	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	116	M.1	M.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	117	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	118	George	George	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	119	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	120	D.1	D.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	121	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	122	Bradley	Bradley	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	123	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	124	M.B.1	M.B.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	125	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	126	Garvin	Garvin	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	127	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	128	J.H.1	J.H.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	129	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	130	Harrison	Harrison	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	131	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	132	L.A.1	L.A.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	133	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	134	Morris	Morris	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	135	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	136	E.1	E.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	137	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	138	Duffy	Duffy	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	139	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	140	D.1	D.1	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	141	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	142	Semidei	Semidei	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	143	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	85	144	Pomales	Pomales	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	145	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	146	M.3	M.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	147	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	148	Baxter	Baxter	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	149	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	85	150	Lowe	Lowe	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	151	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	152	L.A.3	L.A.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	153	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	154	Daniel	Daniel	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	155	-	-	HYPH
work_il2ytikkcvhktlpwxw46dgflri	85	156	Johnson	Johnson	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	157	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	158	J.A.3	J.A.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	159	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	160	Schwartz	Schwartz	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	161	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	162	J.3	J.3	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	163	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	164	Baxter-	Baxter-	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	165	Lowe	Lowe	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	166	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	167	L.A.4	L.A.4	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	168	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	169	Cairo	Cairo	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	170	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	171	M.S.1,3,5	M.S.1,3,5	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	172	1Columbia	1Columbia	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	173	University	University	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	174	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	175	New	New	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	176	York	York	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	177	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	178	NY	NY	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	179	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	85	180	2Columbia	2Columbia	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	181	University	University	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	182	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	183	New	New	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	184	York	York	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	185	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	186	NY	NY	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	187	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	85	188	3Columbia	3Columbia	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	189	University	University	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	190	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	191	New	New	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	192	York	York	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	193	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	194	NY	NY	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	195	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	85	196	4University	4university	NN
work_il2ytikkcvhktlpwxw46dgflri	85	197	of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	85	198	California	California	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	199	San	San	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	200	Francisco	Francisco	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	201	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	202	San	San	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	203	Francisco	Francisco	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	204	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	205	CA	CA	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	206	;	;	:
work_il2ytikkcvhktlpwxw46dgflri	85	207	5Columbia	5Columbia	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	208	University	University	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	209	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	210	New	New	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	211	York	York	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	212	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	213	NY	NY	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	214	Background	Background	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	215	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	85	216	CD341	cd341	NN
work_il2ytikkcvhktlpwxw46dgflri	85	217	stem	stem	NN
work_il2ytikkcvhktlpwxw46dgflri	85	218	cell	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	85	219	selection	selection	NN
work_il2ytikkcvhktlpwxw46dgflri	85	220	depletes	deplete	VBZ
work_il2ytikkcvhktlpwxw46dgflri	85	221	T	t	NN
work_il2ytikkcvhktlpwxw46dgflri	85	222	cells	cell	NNS
work_il2ytikkcvhktlpwxw46dgflri	85	223	responsi-	responsi-	CC
work_il2ytikkcvhktlpwxw46dgflri	85	224	ble	ble	VB
work_il2ytikkcvhktlpwxw46dgflri	85	225	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	85	226	severe	severe	JJ
work_il2ytikkcvhktlpwxw46dgflri	85	227	aGVHD	agvhd	NN
work_il2ytikkcvhktlpwxw46dgflri	85	228	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	85	229	Lang	Lang	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	230	et	et	FW
work_il2ytikkcvhktlpwxw46dgflri	85	231	al	al	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	232	.	.	NNP
work_il2ytikkcvhktlpwxw46dgflri	85	233	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	234	Blood	blood	NN
work_il2ytikkcvhktlpwxw46dgflri	85	235	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	85	236	2003	2003	CD
work_il2ytikkcvhktlpwxw46dgflri	85	237	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	85	238	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	86	1	CD341	CD341	NNP
work_il2ytikkcvhktlpwxw46dgflri	86	2	selected	select	VBN
work_il2ytikkcvhktlpwxw46dgflri	86	3	grafts	graft	NNS
work_il2ytikkcvhktlpwxw46dgflri	86	4	have	have	VBP
work_il2ytikkcvhktlpwxw46dgflri	86	5	been	be	VBN
work_il2ytikkcvhktlpwxw46dgflri	86	6	associated	associate	VBN
work_il2ytikkcvhktlpwxw46dgflri	86	7	with	with	IN
work_il2ytikkcvhktlpwxw46dgflri	86	8	delayed	delay	VBN
work_il2ytikkcvhktlpwxw46dgflri	86	9	IR	IR	NNP
work_il2ytikkcvhktlpwxw46dgflri	86	10	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	86	11	Ball	Ball	NNP
work_il2ytikkcvhktlpwxw46dgflri	86	12	et	et	NNP
work_il2ytikkcvhktlpwxw46dgflri	86	13	al	al	NNP
work_il2ytikkcvhktlpwxw46dgflri	86	14	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	86	15	BMT	BMT	NNP
work_il2ytikkcvhktlpwxw46dgflri	86	16	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	86	17	2005	2005	CD
work_il2ytikkcvhktlpwxw46dgflri	86	18	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	86	19	Eyrich	Eyrich	NNP
work_il2ytikkcvhktlpwxw46dgflri	86	20	et	et	NNP
work_il2ytikkcvhktlpwxw46dgflri	86	21	al	al	NNP
work_il2ytikkcvhktlpwxw46dgflri	86	22	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	86	23	BJH	BJH	NNP
work_il2ytikkcvhktlpwxw46dgflri	86	24	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	86	25	2001	2001	CD
work_il2ytikkcvhktlpwxw46dgflri	86	26	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	86	27	.	.	.
work_il2ytikkcvhktlpwxw46dgflri	87	1	Delayed	delay	VBN
work_il2ytikkcvhktlpwxw46dgflri	87	2	IR	IR	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	3	is	be	VBZ
work_il2ytikkcvhktlpwxw46dgflri	87	4	a	a	DT
work_il2ytikkcvhktlpwxw46dgflri	87	5	significant	significant	JJ
work_il2ytikkcvhktlpwxw46dgflri	87	6	risk	risk	NN
work_il2ytikkcvhktlpwxw46dgflri	87	7	factor	factor	NN
work_il2ytikkcvhktlpwxw46dgflri	87	8	for	for	IN
work_il2ytikkcvhktlpwxw46dgflri	87	9	A	a	DT
work_il2ytikkcvhktlpwxw46dgflri	87	10	Scoring	score	VBG
work_il2ytikkcvhktlpwxw46dgflri	87	11	System	System	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	12	Predicting	Predicting	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	13	Outcome	Outcome	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	14	After	after	IN
work_il2ytikkcvhktlpwxw46dgflri	87	15	Unrelated	Unrelated	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	16	Donor	Donor	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	17	Stem	Stem	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	18	Cell	cell	NN
work_il2ytikkcvhktlpwxw46dgflri	87	19	Transplantation	transplantation	NN
work_il2ytikkcvhktlpwxw46dgflri	87	20	In	in	IN
work_il2ytikkcvhktlpwxw46dgflri	87	21	Primary	Primary	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	22	Refractory	Refractory	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	23	Acute	Acute	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	24	Myeloid	Myeloid	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	25	Leu	Leu	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	26	...	...	.
work_il2ytikkcvhktlpwxw46dgflri	87	27	Hla	Hla	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	28	Disparity	Disparity	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	29	And	and	CC
work_il2ytikkcvhktlpwxw46dgflri	87	30	Rapid	Rapid	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	31	Immune	Immune	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	32	Reconstitution	Reconstitution	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	33	Do	do	VBP
work_il2ytikkcvhktlpwxw46dgflri	87	34	Not	not	RB
work_il2ytikkcvhktlpwxw46dgflri	87	35	Overcome	overcome	VB
work_il2ytikkcvhktlpwxw46dgflri	87	36	Propensity	propensity	NN
work_il2ytikkcvhktlpwxw46dgflri	87	37	To	to	IN
work_il2ytikkcvhktlpwxw46dgflri	87	38	Relapse	relapse	VB
work_il2ytikkcvhktlpwxw46dgflri	87	39	In	in	IN
work_il2ytikkcvhktlpwxw46dgflri	87	40	Patients	Patients	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	41	Undergoing	undergo	VBG
work_il2ytikkcvhktlpwxw46dgflri	87	42	Haploidentical	haploidentical	JJ
work_il2ytikkcvhktlpwxw46dgflri	87	43	H	h	NN
work_il2ytikkcvhktlpwxw46dgflri	87	44	...	...	:
work_il2ytikkcvhktlpwxw46dgflri	87	45	Anti	Anti	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	46	-	-	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	47	Hla	hla	JJ
work_il2ytikkcvhktlpwxw46dgflri	87	48	Antibodies	Antibodies	NNPS
work_il2ytikkcvhktlpwxw46dgflri	87	49	Predict	Predict	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	50	Graft	Graft	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	51	Failure	Failure	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	52	,	,	,
work_il2ytikkcvhktlpwxw46dgflri	87	53	Time	Time	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	54	To	to	IN
work_il2ytikkcvhktlpwxw46dgflri	87	55	Engraftment	Engraftment	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	56	And	and	CC
work_il2ytikkcvhktlpwxw46dgflri	87	57	Umbilical	Umbilical	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	58	Cord	Cord	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	59	Unit	Unit	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	60	Dominance	dominance	IN
work_il2ytikkcvhktlpwxw46dgflri	87	61	In	in	IN
work_il2ytikkcvhktlpwxw46dgflri	87	62	Double	double	JJ
work_il2ytikkcvhktlpwxw46dgflri	87	63	Umbilical	umbilical	JJ
work_il2ytikkcvhktlpwxw46dgflri	87	64	Cord	cord	NN
work_il2ytikkcvhktlpwxw46dgflri	87	65	B	b	NN
work_il2ytikkcvhktlpwxw46dgflri	87	66	...	...	:
work_il2ytikkcvhktlpwxw46dgflri	87	67	Ex	Ex	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	68	Vivo	Vivo	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	69	Treatment	Treatment	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	70	Of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	87	71	Hematopoietic	Hematopoietic	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	72	Stem	stem	NN
work_il2ytikkcvhktlpwxw46dgflri	87	73	Cells	cell	NNS
work_il2ytikkcvhktlpwxw46dgflri	87	74	With	with	IN
work_il2ytikkcvhktlpwxw46dgflri	87	75	16,16-Dimethyl	16,16-dimethyl	CD
work_il2ytikkcvhktlpwxw46dgflri	87	76	Prostaglandin	prostaglandin	NN
work_il2ytikkcvhktlpwxw46dgflri	87	77	E2	e2	NN
work_il2ytikkcvhktlpwxw46dgflri	87	78	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	87	79	Ft1050	Ft1050	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	80	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	87	81	Improves	improve	VBZ
work_il2ytikkcvhktlpwxw46dgflri	87	82	Engraftment	Engraftment	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	83	And	and	CC
work_il2ytikkcvhktlpwxw46dgflri	87	84	Hemato	Hemato	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	85	...	...	:
work_il2ytikkcvhktlpwxw46dgflri	87	86	Allogeneic	Allogeneic	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	87	Transplantation	Transplantation	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	88	Using	use	VBG
work_il2ytikkcvhktlpwxw46dgflri	87	89	Haploidentical	haploidentical	JJ
work_il2ytikkcvhktlpwxw46dgflri	87	90	Donor	donor	NN
work_il2ytikkcvhktlpwxw46dgflri	87	91	Versus	Versus	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	92	Unrelated	Unrelated	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	93	Cord	Cord	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	94	Blood	Blood	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	95	Donor	Donor	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	96	:	:	:
work_il2ytikkcvhktlpwxw46dgflri	87	97	A	a	DT
work_il2ytikkcvhktlpwxw46dgflri	87	98	Single	Single	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	99	Center	Center	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	100	Retrospective	Retrospective	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	101	Study	Study	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	102	Cd34	Cd34	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	103	+	+	CC
work_il2ytikkcvhktlpwxw46dgflri	87	104	Stem	Stem	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	105	Cell	Cell	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	106	Selection	Selection	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	107	And	and	CC
work_il2ytikkcvhktlpwxw46dgflri	87	108	Cd3	cd3	CD
work_il2ytikkcvhktlpwxw46dgflri	87	109	+	+	CD
work_il2ytikkcvhktlpwxw46dgflri	87	110	Addback	Addback	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	111	For	for	IN
work_il2ytikkcvhktlpwxw46dgflri	87	112	Pediatric	Pediatric	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	113	Recipients	Recipients	NNPS
work_il2ytikkcvhktlpwxw46dgflri	87	114	Of	of	IN
work_il2ytikkcvhktlpwxw46dgflri	87	115	Matched	Matched	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	116	Unrelated	Unrelated	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	117	Adult	Adult	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	118	Donor	Donor	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	119	(	(	-LRB-
work_il2ytikkcvhktlpwxw46dgflri	87	120	Mud	Mud	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	121	)	)	-RRB-
work_il2ytikkcvhktlpwxw46dgflri	87	122	Peripheral	Peripheral	NNP
work_il2ytikkcvhktlpwxw46dgflri	87	123	Blood	blood	NN
work_il2ytikkcvhktlpwxw46dgflri	87	124	...	...	.